Data / Research funding / Hypertension
Hypertension: 1,236 NIH awards ($1.9B) to 251 organizations
1,236 NIH awards ($1.9B) in the NIH spending category Hypertension, to 251 organizations, read 2026-11-04. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
The 500 largest of 1,236 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| NHLBI Community Engagement Technical Assistance Center (CETAC) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $367,122,105 | September 25, 2020 | August 31, 2026 | BAYTOP, CHANZA | reporter.nih.gov |
| Scientific Information Management and Literature-Based Evaluations for the DTT - Support for Scoping Activities of Cardiovascular Toxicity and Disease | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $31,920,740 | January 10, 2025 | July 9, 2025 | BURCH, DAVID | reporter.nih.gov |
| The Mid-Atlantic Center for Cardiometabolic Health (MACCH) | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $24,163,298 | September 24, 2021 | June 30, 2027 | COOPER, LISA A | reporter.nih.gov |
| The Indiana University-Ohio State University Maternal and Pediatric Precision in Therapeutics Data, Model, Knowledge, and Research Coordination Center (IU-OSU MPRINT DMKRCC) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $17,481,052 | September 10, 2021 | July 31, 2027 | QUINNEY, SARA K | reporter.nih.gov |
| Continuation of the NuMoM2b Heart Health Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $17,402,772 | February 15, 2020 | January 31, 2027 | MCNEIL, REBECCA BOEHM | reporter.nih.gov |
| MIND DIET AND DEMENTIA PREVENTION IN ISCHEMIC STROKE PATIENTS | NIH | National Institute on Aging | 2021 to 2025 | $13,186,351 | September 1, 2020 | May 31, 2027 | AGGARWAL, NEELUM T. | reporter.nih.gov |
| Integrating lifecourse approaches, biologic and digital phenotypes in support of heart and lung disease epidemiologic research | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $12,991,264 | February 8, 2019 | January 31, 2027 | CHAVARRO, JORGE EDUARDO | reporter.nih.gov |
| Metabolic Basis of Disease - Phase 2 | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $11,560,620 | March 1, 2020 | July 31, 2030 | STEPHENS, JACQUELINE M | reporter.nih.gov |
| Remote Monitoring and Virtual Collaborative Care for Hypertension Control to Prevent Cognitive Decline | NIH | National Institute on Aging | 2021 to 2024 | $11,354,079 | August 1, 2020 | July 31, 2025 | GUPTA, ADITI | reporter.nih.gov |
| Pregnancy as a Window to the Future: Outcomes of Antihypertensive Therapy and Superimposed Preeclampsia in Pregnant Women with Mild Chronic Hypertension (CHAP Maternal Follow-up Study) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $10,486,985 | September 1, 2014 | August 31, 2026 | TITA, ALAN THEVENET N. | reporter.nih.gov |
| Nutrition Precision Health for All of Us (Chicago Center) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $10,228,129 | December 10, 2021 | November 30, 2026 | VAN HORN, LINDA VERNER | reporter.nih.gov |
| Longitudinal Relationships Among Sleep, Cognition and Alzheimer's Disease Biomarkers: Discerning Causal Associations, Mediators and Susceptibility | NIH | National Institute on Aging | 2021 to 2024 | $9,901,034 | May 1, 2021 | February 28, 2026 | REDLINE, SUSAN S. | reporter.nih.gov |
| Impact of Intensive Treatment of Systolic Blood Pressure on Brain Perfusion, Amyloid and Tau in Older Adults (IPAT-study) | NIH | National Institute on Aging | 2022 to 2025 | $9,488,371 | August 1, 2022 | July 31, 2027 | ZHANG, RONG | reporter.nih.gov |
| Race / Ethncicity, Hypertension and Prevention of VCID and Stroke after Intracerebral Hemmorrhage | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $8,210,604 | February 1, 2016 | July 31, 2027 | ROSAND, JONATHAN | reporter.nih.gov |
| Improving the Detection of Hypertension and its Control | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $7,976,047 | February 15, 2022 | January 31, 2027 | ABDALLA, MARWAH | reporter.nih.gov |
| The POINTER Neurovascular Ancillary Study | NIH | National Institute on Aging | 2021 to 2024 | $7,761,498 | April 15, 2020 | December 31, 2025 | BRINKLEY, TINA E | reporter.nih.gov |
| 1/3 A randomized controlled trial of frozen embryo transfers performed in modified natural versus programmed cycles (NatPro) | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $6,197,105 | September 26, 2019 | August 31, 2025 | BAKER, VALERIE LYNN | reporter.nih.gov |
| Effectiveness of Implementing an Intensive Blood Pressure Reduction Intervention on Cognitive Decline in Low-income and Minority Hypertensive Patients | NIH | National Institute on Aging | 2021 to 2024 | $6,046,063 | August 1, 2020 | July 31, 2025 | MILLS, KATHERINE TERESA | reporter.nih.gov |
| Examining Effects of Intensive BP Control on MCI/Dementia and Plasma Biomarker Trajectories by AD Pathology: Elucidating neuroprotective effects in the racially and ethnically diverse SPRINT trial | NIH | National Institute on Aging | 2025 | $5,789,766 | September 30, 2025 | June 30, 2030 | BRESS, ADAM P | reporter.nih.gov |
| A longitudinal cohort study to evaluate cardiovascular risk factors and disease in Haiti - 2 | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $5,606,044 | August 1, 2018 | June 30, 2028 | MCNAIRY, MARGARET LEIGHTON | reporter.nih.gov |
| A Dose Escalation Study of Low Dose Aspirin for the Prevention of Recurrent Preterm Birth | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $5,344,357 | June 10, 2024 | March 31, 2029 | CLIFTON, REBECCA GERSNOVIEZ | reporter.nih.gov |
| IGNITE EP2 - Admin Supplement | NIH | National Human Genome Research Institute | 2021 to 2024 | $5,199,656 | July 1, 2024 | June 30, 2025 | CAVALLARI, LARISA HUMMA | reporter.nih.gov |
| IND Enabling Studies for RASRx 1902, a novel Mas receptor agonist, for treatment of cognitive impairment in patients at risk for Alzheimer's disease. | NIH | National Institute on Aging | 2021 to 2023 | $4,958,940 | May 1, 2020 | April 30, 2026 | RODGERS, KATHLEEN E. | reporter.nih.gov |
| Preventing Cognitive Decline by Reducing BP Target Trial (PCOT) | NIH | National Institute on Aging | 2021 to 2024 | $4,956,317 | September 1, 2020 | August 31, 2025 | VAZQUEZ, MIGUEL A | reporter.nih.gov |
| Influence of Prenatal and Early Childhood Home-Visiting by Nurses on Development of Chronic Disease: 29-year Follow-Up of a Randomized Clinical Trial | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $4,890,503 | June 22, 2020 | May 31, 2026 | OLDS, DAVID L | reporter.nih.gov |
| Implementing and Scaling Up a Team-based Care Strategy for Hypertension Control in Colombia and Jamaica | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $4,815,150 | September 15, 2020 | August 31, 2027 | TULLOCH-REID, MARSHALL KERR | reporter.nih.gov |
| Offspring Neurodevelopment and Growth after Early Antihypertensive Therapy OR Preeclampsia in Women with Chronic Hypertension and Pregnancy (CHAP Child). | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $4,709,482 | September 20, 2023 | May 31, 2028 | TITA, ALAN THEVENET N. | reporter.nih.gov |
| Prognostic Implications of Home-Based Blood Pressure Monitoring in Older Adults | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,461,092 | July 20, 2021 | May 31, 2027 | JURASCHEK, STEPHEN P | reporter.nih.gov |
| VCID Center Without Walls for Understanding and Leveraging Small Vessel Cerebrovascular Disease Mechanisms in ADRD | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $4,361,625 | September 24, 2024 | August 31, 2027 | LEE, JIN-MOO | reporter.nih.gov |
| Alive Blood Pressure Project: A church-based intervention to improve blood pressure | NIH | National Institute of Nursing Research | 2021 to 2025 | $4,281,131 | May 1, 2020 | March 31, 2026 | LYNCH, ELIZABETH B | reporter.nih.gov |
| Cardiorenal Genomics for Risk Prediction in African Descent Populations | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,261,183 | September 1, 2021 | August 31, 2028 | IRVIN, MARGUERITE R | reporter.nih.gov |
| From GWAS loci to blood pressure genes, variants & mechanisms - Renewal | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,230,070 | September 1, 2007 | March 31, 2027 | CHAKRAVARTI, ARAVINDA | reporter.nih.gov |
| Addressing HyperteNsion and Diabetes through Community-Engaged Systems in Puno Peru (ANDES study) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $4,214,806 | September 30, 2020 | January 31, 2027 | HARTINGER, STELLA MARIA | reporter.nih.gov |
| Addressing antihypertensive medication adherence through EHR-enabled teamlets in primary care - Resubmission - 1 | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,978,996 | May 1, 2021 | April 30, 2027 | BLECKER, SAUL B. | reporter.nih.gov |
| Preeclampsia and the Brain: Small vessel disease and cognitive function in early midlife | NIH | National Institute on Aging | 2022 to 2025 | $3,960,160 | February 1, 2022 | November 30, 2026 | CATOV, JANET M | reporter.nih.gov |
| Community Mobilization for Improved Clean Cookstove Uptake, Household Air Pollution Reduction, and Hypertension Prevention | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,941,241 | July 15, 2021 | June 30, 2027 | OGEDEGBE, OLUGBENGA G. | reporter.nih.gov |
| Actions to Decrease Disparities in Risk and Engage in Shared Support for Blood Pressure Control (ADDRESS-BP) in Blacks | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,933,523 | September 10, 2020 | August 31, 2027 | OGEDEGBE, OLUGBENGA G. | reporter.nih.gov |
| Arterial stiffness in mother/infant dyads: Life course approach to prevent cardiovascular disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,814,826 | August 1, 2021 | July 31, 2025 | MEYER, MICHELLE | reporter.nih.gov |
| Home Blood Pressure in Hemodialysis (HOME-BP) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,791,550 | May 1, 2021 | April 30, 2027 | BANSAL, NISHA | reporter.nih.gov |
| Bridging the evidence-to-practice gap: Evaluating practice facilitation as a strategy to accelerate translation of a systems-level adherence intervention into safety net practices | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2023 | $3,762,006 | April 9, 2019 | December 31, 2024 | SCHOENTHALER, ANTOINETTE M | reporter.nih.gov |
| Aspirin to prevent cardiac dysfunction in preeclampsia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,760,353 | January 1, 2021 | December 31, 2026 | SHAHUL, SAJID | reporter.nih.gov |
| Blood Pressure, Obesity, and Diabetes in Relation to Perinatal and Postpartum Complications | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,700,262 | April 1, 2021 | March 31, 2027 | ZHU, YEYI | reporter.nih.gov |
| Peripheral Sympathetic Dysfunction in Cardiac Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,691,327 | April 1, 2020 | April 30, 2028 | HABECKER, BETH A | reporter.nih.gov |
| PPARG-dependent Mechanisms Control Endothelial-Smooth Muscle Coordination, Arterial Pressure, Vasomotor Function and Arterial Stiffness | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,677,520 | February 6, 2019 | April 30, 2025 | SIGMUND, CURT DANIEL | reporter.nih.gov |
| Multiple Chronic COnditions: MultiPle dAta SouRcEs (MC COMPARE) | NIH | National Institute on Aging | 2023 to 2025 | $3,665,706 | September 1, 2023 | May 31, 2027 | DORR, DAVID A. | reporter.nih.gov |
| Molecular and Physiological Mechanisms of Hypertensive Cerebral Microangiopathy | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $3,627,088 | July 1, 2020 | April 30, 2026 | GUROL, MAHMUT EDIP | reporter.nih.gov |
| Implementing genomic medicine through pragmatic trials in diverse and underserved populations across Indiana. | NIH | National Human Genome Research Institute | 2021 to 2024 | $3,584,747 | September 19, 2018 | June 30, 2025 | SKAAR, TODD C. | reporter.nih.gov |
| Evaluating the Implementation and Scale-Up of Nigeria National Sodium Reduction Program | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,539,349 | September 15, 2020 | August 31, 2027 | OJJI, DIKE BEVIS | reporter.nih.gov |
| Implementing Remote Patient Monitoring to Improve Hypertension Control in a Primary Care Network | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,519,987 | June 15, 2021 | May 31, 2027 | KRONISH, IAN MATTHEW | reporter.nih.gov |
| Rosettes in Adrenal Development, Maintenance and Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,510,880 | September 19, 2019 | June 30, 2029 | BREAULT, DAVID T | reporter.nih.gov |
| Improving Blood Pressure Screening and Treatment Strategies in Young Adults | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,497,809 | July 1, 2021 | May 31, 2027 | AN, JAEJIN | reporter.nih.gov |
| Primary Aldosteronism Subtypes: Pathophysiology and Steroid Signatures | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,494,786 | January 7, 2021 | March 31, 2027 | TURCU, ADINA F | reporter.nih.gov |
| SPRINT MIND 2020 | NIH | National Institute on Aging | 2021 to 2023 | $3,485,934 | June 15, 2017 | May 31, 2025 | REBOUSSIN, DAVID M | reporter.nih.gov |
| Sleep Apnea-Specific Nocturnal Blood Pressure Surge to Determine Cardiovascular Risks and Therapeutic Benefits in Patients with Obstructive Sleep Apnea | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,481,554 | September 1, 2021 | July 31, 2027 | KWON, YOUNGHOON | reporter.nih.gov |
| Aldosterone, the Mineralocorticoid Receptor, and Cardiovascular Disease in Obesity | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,475,737 | September 15, 2020 | August 31, 2025 | VAIDYA, ANAND | reporter.nih.gov |
| Integrated, Individualized, and Intelligent Prescribing (I3P) Clinical Trial Network | NIH | National Human Genome Research Institute | 2021 to 2024 | $3,458,289 | July 1, 2024 | June 30, 2025 | PETERSON, JOSEPH F. | reporter.nih.gov |
| A Just-In-Time Adaptive Mobile Application Intervention To Reduce Sodium Intake And Blood Pressure In Hypertensive Patients | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,449,450 | September 5, 2022 | August 31, 2026 | DORSCH, MICHAEL | reporter.nih.gov |
| The Role of Neighborhood Greenspace in reducing Risk of Hypertensive Disorders of Pregnancy, Chronic Hypertension, and Racial Disparities in Maternal Morbidity | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,434,907 | January 15, 2022 | December 31, 2026 | SOUTH, EUGENIA C | reporter.nih.gov |
| Effects of DASH Groceries on Blood Pressure in Black Residents of Urban Food Deserts | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $3,425,621 | June 18, 2022 | February 28, 2027 | JURASCHEK, STEPHEN P | reporter.nih.gov |
| OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP). | NIH | National Institute of Nursing Research | 2021 to 2025 | $3,414,593 | August 13, 2021 | May 31, 2027 | STILL, CAROLYN HARMON | reporter.nih.gov |
| Community Intervention to Reduce CardiovascuLar Disease in Chicago (CIRCL-Chicago) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,414,401 | September 10, 2020 | August 31, 2027 | KHO, ABEL N. | reporter.nih.gov |
| Metabolic and neural activity normalization by cerebral blood flow increase in AD/ADRD models | NIH | National Institute on Aging | 2023 to 2025 | $3,391,148 | April 15, 2023 | January 31, 2028 | SCHAFFER, CHRIS B | reporter.nih.gov |
| Actions to Decrease Disparities in Risk and Engage in Shared Support for Blood Pressure Control (ADDRESS-BP) in Blacks | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $3,374,734 | September 10, 2020 | August 31, 2023 | OGEDEGBE, OLUGBENGA G. | reporter.nih.gov |
| Avoiding (Heart) Failure: Physiologic-Based Targeting of the RAAS to Treat Subclinical HFpEF among PWH | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,365,562 | January 15, 2020 | December 31, 2025 | SRINIVASA, SUMAN | reporter.nih.gov |
| Supporting Tailored Adaptive Change and Reinforcement for Medication Adherence Program (STAR-MAP): Randomized trial of a novel approach to improve adherence in older hypertensive women and men | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,351,354 | May 1, 2021 | April 30, 2027 | KROUSEL-WOOD, MARIE | reporter.nih.gov |
| Informing optimal first-line antihypertensive therapy: A rigorous comparative effectiveness analysis of ARBs vs. ACEIs on long-term risk of dementia, cancer, heart disease, and quality of life | NIH | National Institute on Aging | 2022 to 2025 | $3,339,134 | March 15, 2022 | December 31, 2026 | COHEN, JORDANA B. | reporter.nih.gov |
| The Video-based Intervention to Reduce Hypertension Treatment and OUtcome Differences in Adults Living with Stroke or Transient Ischemic Attack (VIRTUAL) | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $3,254,165 | September 18, 2021 | May 31, 2027 | SHARRIEF, ANJAIL Z | reporter.nih.gov |
| Anatomy of the circle of Willis, cerebral blood flow, and Alzheimer's disease biomarkers in hypertension | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,226,267 | March 6, 2012 | March 31, 2027 | GLODZIK, LIDIA | reporter.nih.gov |
| Mitochondrial health, cardiovascular risk, and blood pressure targets in hypertensive adults | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,222,133 | September 1, 2021 | July 31, 2026 | JOTWANI, VASANTHA KOLAVENNU | reporter.nih.gov |
| Multi-ethnic Multi-level Strategies and Behavioral Economics to Eliminate Hypertension Disparities in LA County. | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,206,956 | September 10, 2020 | August 31, 2027 | BROWN, ARLEEN F. | reporter.nih.gov |
| Integrating HIV and hEART health in South Africa (iHeart-SA) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $3,190,246 | September 25, 2020 | August 31, 2025 | VENTER, FRANCOIS | reporter.nih.gov |
| Postpartum Remote Blood Pressure Monitoring Program: Study of Reducing Severe Maternal Morbidity among Black and Latina Women by Incorporating Patient Experiences and Systems Science | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,166,679 | August 1, 2021 | September 30, 2026 | KELLEHER, SAMANTHA PARKER | reporter.nih.gov |
| Investigating Mixed Lineage Kinase 3 as a blood pressure-independent protein kinase G1 effector in heart failure | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,153,099 | May 15, 2022 | April 30, 2027 | BLANTON, ROBERT MORRIS | reporter.nih.gov |
| Applying Hypertension Clinical Trials to Real World Adults with CKD | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,151,118 | September 24, 2021 | May 31, 2027 | KURELLA TAMURA, MANJULA | reporter.nih.gov |
| The role of semen in induction of paternal-specific tolerance during pregnancy | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2025 | $3,142,758 | February 25, 2021 | January 31, 2027 | VOJTECH, LUCIA N | reporter.nih.gov |
| The ALOHA trial: Addressing Quality of Life, Clinical Outcomes, and Mechanisms in Uncontrolled Asthma Following the DASH Dietary Pattern | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,123,405 | September 20, 2021 | August 31, 2027 | MA, JUN | reporter.nih.gov |
| The Role of Vascular MR-Regulated Genes in Vascular Function and Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,122,397 | July 15, 2009 | March 31, 2026 | JAFFE, IRIS Z | reporter.nih.gov |
| Blood Pressure and ADRD in African Americans: the Jackson Heart Study | NIH | National Institute on Aging | 2021 to 2022 | $3,111,832 | September 15, 2019 | August 31, 2022 | PALTA, PRIYA | reporter.nih.gov |
| Disrupted Sleep in Somali Americans – Implications for Hypertension Risk | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,097,975 | June 10, 2022 | May 31, 2027 | SOMERS, VIREND K | reporter.nih.gov |
| Discovery, Replication, and Validation of Biomarkers of the DASH Diet and Hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,096,045 | September 1, 2021 | July 31, 2026 | REBHOLZ, CASEY MARIE | reporter.nih.gov |
| High Salt Remodels Renal Cortical and Proximal Tubular Metabolism: Metabolic Fuels, Oxidative Stress, and Hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,089,494 | January 1, 2021 | November 30, 2028 | COWLEY, ALLEN W | reporter.nih.gov |
| Neuroimmune mechanisms underlying electroacupuncture effect on vascular function | NIH | National Center for Complementary & Integrative Health | 2021 to 2025 | $3,088,801 | August 16, 2021 | July 31, 2026 | MALIK, SHAISTA | reporter.nih.gov |
| Pharmacist-CHW Team to Improve Medication Adherence and Reduce Hypertension Disparities | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,048,975 | September 6, 2021 | June 30, 2026 | LEE, JEANNIE KIM | reporter.nih.gov |
| Wearable Multi-modality Cuffless Blood Pressure Monitoring | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2024 | $3,047,882 | May 1, 2021 | January 31, 2026 | ZHANG, QUAN | reporter.nih.gov |
| Church Wellness Coordinator-led Intervention to Improve Hypertension Control in the Black Community | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2024 | $3,039,956 | September 18, 2022 | July 22, 2024 | HE, JIANG | reporter.nih.gov |
| Immune Mechanisms of Salt-Sensitive hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,002,912 | May 4, 2021 | April 30, 2026 | KIRABO, ANNET | reporter.nih.gov |
| Church Wellness Coordinator–Led Intervention to Improve Hypertension Control in Communities | NIH | National Institute on Minority Health and Health Disparities | 2024 to 2025 | $2,996,016 | September 18, 2022 | November 30, 2027 | HE, JIANG | reporter.nih.gov |
| Mechanisms of Immune Activation in Hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,991,557 | February 1, 2018 | December 31, 2025 | HARRISON, DAVID G | reporter.nih.gov |
| Automated clinic blood pressure assessment and detection of white coat and masked hypertension study in African Americans | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,989,796 | February 10, 2020 | January 31, 2027 | ABDALLA, MARWAH | reporter.nih.gov |
| FIM+DASH: A randomized Food Is Medicine trial to promote healthy eating and blood pressure control in hypertensive Black women with obesity | NIH | National Institute on Minority Health and Health Disparities | 2025 | $2,979,575 | September 14, 2025 | June 30, 2029 | LOFTON, SARIA | reporter.nih.gov |
| Using mHealth to improve adherence and reduce blood pressure in individuals with hypertension and bipolar disorder | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,965,831 | August 17, 2020 | April 30, 2026 | LEVIN, JENNIFER BETH | reporter.nih.gov |
| Natriuretic Peptide-Renin-Angiotensin-Aldosterone System Rhythm Axis and Nocturnal Blood Pressure | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,942,464 | January 5, 2022 | December 31, 2026 | ARORA, PANKAJ | reporter.nih.gov |
| The impact of enculturation on the epigenetic relationship between chronic stress and hypertension in Yup'ik Alaska Native people | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $2,921,720 | February 2, 2021 | December 31, 2026 | BOYER, BERT BRANDON | reporter.nih.gov |
| Angiotensins, Prostaglandins and Adrenergic Interactions | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,917,328 | September 1, 1977 | March 31, 2027 | MALIK, KAFAIT U | reporter.nih.gov |
| Incorporation of a Hypertension Working Group into the Jackson Heart Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,899,917 | July 15, 2013 | June 30, 2025 | LEWIS, CORA E | reporter.nih.gov |
| Cost Extension for Ramon Ayon Diversity Supplement | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,898,875 | January 15, 2020 | November 30, 2024 | SOMLYO, AVRIL V. | reporter.nih.gov |
| Atheroprotection by smooth muscle selective RhoGAPs | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,891,948 | August 1, 2022 | July 31, 2027 | TAYLOR, JOAN M | reporter.nih.gov |
| Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,871,936 | August 1, 2021 | July 31, 2027 | EGBE, ALEXANDER | reporter.nih.gov |
| Sedentary behavior, physical activity, sleep, and cardiovascular risk in pregnancy: the Pregnancy 24/7 cohort study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,868,051 | September 15, 2020 | August 31, 2025 | WHITAKER, KARA MARIE | reporter.nih.gov |
| Anion channel regulation of vascular superoxide signaling in hypertension | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,851,392 | June 15, 2022 | May 31, 2027 | LAMB, FRED S | reporter.nih.gov |
| Integrative omics of preeclampsia in TOPMED and maternal cardiovascular health | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,846,673 | April 15, 2022 | March 31, 2026 | SAXENA, RICHA | reporter.nih.gov |
| Navigating Hypertension and Food Insecurity: A Produce Prescription Program to Improve Health Outcomes for Native Hawaiian and Pacific Islander Communities | NIH | National Institute on Minority Health and Health Disparities | 2025 | $2,834,272 | September 1, 2025 | June 30, 2029 | ESQUIVEL, MONICA KAZLAUSKY | reporter.nih.gov |
| Multilevel mobile health program to improve rural hypertension | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,826,974 | July 1, 2022 | June 30, 2027 | MAGNANI, JARED W. | reporter.nih.gov |
| Hypertension and Cardiorenal Research Training Program | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,818,763 | September 20, 2010 | August 31, 2030 | GRANGER, JOEY P. | reporter.nih.gov |
| Paracrine TNF signaling impairs endothelial TRPV4 microdomains in obesity | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,809,665 | June 1, 2019 | May 31, 2028 | SONKUSARE, SWAPNIL K. | reporter.nih.gov |
| Inspiratory muscle strength training for lowering systolic blood pressure in midlife and older adults with chronic kidney disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,803,942 | September 1, 2021 | June 30, 2027 | CHONCHOL, MICHEL BENJAMIN | reporter.nih.gov |
| Transcriptional Regulation by Angiotensin II in Vascular Smooth Muscle Cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,801,471 | January 1, 2011 | April 30, 2026 | NATARAJAN, RAMA | reporter.nih.gov |
| Severe Maternal Morbidity: An Investigation of Joint Impacts of Risk Factors and Cumulative Risks Across Successive Pregnancies | NIH | National Institute of Nursing Research | 2021 to 2025 | $2,779,271 | January 19, 2018 | March 31, 2028 | CARMICHAEL, SUZAN L | reporter.nih.gov |
| Blood Pressure Control During Exercise in Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,772,420 | July 8, 1996 | March 31, 2026 | O'LEARY, DONAL S | reporter.nih.gov |
| Novel Therapeutics for Cardiovascular Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,762,670 | May 12, 2022 | August 31, 2026 | SANGARALINGHAM, SASANTHA JESON | reporter.nih.gov |
| Mechanisms of mindfulness training to prevent hypertensive disorders of pregnancy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,751,777 | September 1, 2021 | June 30, 2027 | BUBLITZ, MARGARET | reporter.nih.gov |
| Automated detection of microstructural features that have unique protein markers and are prognostic for chronic kidney disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,739,114 | February 10, 2011 | January 31, 2027 | RULE, ANDREW DAVID | reporter.nih.gov |
| Modeling informatics data to track maternal risk and care quality | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,737,921 | September 8, 2022 | August 31, 2027 | FRIEDMAN, ALEXANDER M | reporter.nih.gov |
| Electronic Tools to Increase Recognition and Improve Primary Care Management for Hypertension in Chronic Kidney Disease: A Multi-site Randomized Clinical Trial | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,737,895 | September 1, 2018 | June 30, 2030 | SAMAL, LIPIKA | reporter.nih.gov |
| A sensor-controlled digital game-based approach to improve self-care behaviors among adults diagnosed with hypertension in a Native American community | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,737,408 | May 1, 2022 | April 30, 2027 | RADHAKRISHNAN, KAVITA | reporter.nih.gov |
| PRegnancy OuTcomEs and subclinical Cardiovascular disease sTudy: (PROTECT) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,732,522 | December 6, 2021 | November 30, 2026 | KHAN, SADIYA SANA | reporter.nih.gov |
| Renal AT2 Receptors in Hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,730,789 | January 1, 2021 | December 31, 2025 | KELLER, SUSANNA R | reporter.nih.gov |
| A Mechanistic Trial of Dietary Sodium Reduction on Vascular Structure and Function in African Americans | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,726,718 | January 17, 2022 | December 31, 2026 | MILLS, KATHERINE TERESA | reporter.nih.gov |
| Metabolic and Vascular Factors in tau pathogenesis | NIH | National Institute on Aging | 2021 to 2024 | $2,720,466 | September 15, 2020 | May 31, 2025 | FRAUTSCHY, SALLY ANN | reporter.nih.gov |
| HIV, Sleep, Nocturnal Non-dipping, and Cardiovascular Disease: a Tanzanian Cohort | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,717,936 | September 20, 2021 | August 31, 2027 | PECK, ROBERT N | reporter.nih.gov |
| PULESA-UGANDA-Strengthening the Blood Pressure Care and Treatment cascade for Ugandans living with HIV-ImpLEmentation Strategies to SAve lives | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $2,717,844 | September 10, 2020 | August 31, 2025 | SEMITALA, FRED C | reporter.nih.gov |
| Intermittent hypoxia and hypertension: Role of the lamina terminalis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,713,982 | January 18, 2021 | December 31, 2025 | FARMER, GEORGE EDWARD | reporter.nih.gov |
| Inspiratory muscle strength training for lowering blood pressure and improving endothelial function in postmenopausal women: comparison with "standard of care" aerobic exercise | NIH | National Institute on Aging | 2021 to 2025 | $2,713,806 | June 1, 2021 | February 28, 2027 | SEALS, DOUGLAS R | reporter.nih.gov |
| Mechanical Stress-Dependent Remodeling of the Cardiac Microtubule Network | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,712,049 | March 1, 2020 | February 28, 2026 | MARGULIES, KENNETH BER | reporter.nih.gov |
| Violence, substance use, sleep disturbances, and hypertension among women with HIV: A syndemic approach (VS2H2 Syndemic) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,711,695 | September 15, 2021 | July 31, 2025 | LIM, SAHNAH | reporter.nih.gov |
| Determinants and Cardiovascular Consequences of Disparities in Sleep and Circadian Rhythms between Black and White Adults | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,706,249 | July 15, 2020 | June 30, 2025 | CARNETHON, MERCEDES RENEE | reporter.nih.gov |
| Neuroimmune dynamics involved in the pathogenesis of hypertension after psychological trauma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,702,631 | July 20, 2021 | May 31, 2027 | CASE, ADAM J | reporter.nih.gov |
| COVID-19 shutdown: impact of healthcare disruptions on cardiovascular health disparities among people with multiple chronic conditions in New York City. | NIH | National Institute on Aging | 2022 to 2025 | $2,701,968 | September 30, 2022 | June 30, 2027 | DODSON, JOHN A | reporter.nih.gov |
| Neuroendocrine dysfunction and hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,686,584 | July 1, 2021 | June 30, 2026 | LI, DE-PEI | reporter.nih.gov |
| The role of the innate immune cell cyclooxygenase/prostaglandin system in blood pressureregulation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,667,442 | December 20, 2002 | June 30, 2028 | HARRIS, RAYMOND C. | reporter.nih.gov |
| T cell homing to the kidney contributes to salt retention and blood pressure regulation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,663,886 | April 10, 2019 | March 31, 2029 | MU, SHENGYU | reporter.nih.gov |
| Understanding causal mechanisms in preeclampsia through genetic instrumental variables | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,642,565 | January 5, 2022 | December 31, 2026 | GIRI, AYUSH | reporter.nih.gov |
| AirPressureNYC: Reducing AIR pollution to lower blood PRESSURE among New York City public housing residents | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,638,430 | July 15, 2023 | June 30, 2028 | NEWMAN, JONATHAN D | reporter.nih.gov |
| Time-efficient inspiratory muscle strength training for improving blood pressure and vascular function in older adults with sleep-disordered breathing | NIH | National Institute on Aging | 2021 to 2025 | $2,635,424 | September 30, 2020 | May 31, 2027 | BAILEY, E. FIONA | reporter.nih.gov |
| Leveraging electronic health record tools to reduce health disparities for patients with uncontrolled hypertension | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2024 | $2,630,154 | March 9, 2020 | December 31, 2025 | CHOUDHRY, NITEESH K | reporter.nih.gov |
| Integration of Hypertension Management into HIV Care in Nigeria: A Task Strengthening Strategy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,628,921 | February 15, 2020 | January 31, 2026 | OGEDEGBE, OLUGBENGA G. | reporter.nih.gov |
| Identifying Successful Strategies for Implementing Team-Based Home Blood Pressure Monitoring in Primary Care | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,622,028 | September 10, 2022 | August 31, 2026 | FISCELLA, KEVIN ANTHONY | reporter.nih.gov |
| Hemodynamic Effects of Positive Airway Pressure to Treat Supine Hypertension and Improve Neurogenic Orthostatic Hypotension | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,620,737 | December 1, 2021 | November 30, 2026 | BIAGGIONI, ITALO | reporter.nih.gov |
| Benefits and Harms of Antihypertensive Management Strategies for Nursing Home Residents with ADRD | NIH | National Institute on Aging | 2025 | $2,612,229 | September 1, 2025 | August 31, 2029 | HARRIS, DANIEL | reporter.nih.gov |
| Effects of a behavioral sleep extension intervention on cardiometabolic risk factors among patients with elevated BP/hypertension | NIH | National Institute of Nursing Research | 2021 to 2024 | $2,608,103 | September 25, 2020 | June 30, 2026 | BARON, KELLY GLAZER | reporter.nih.gov |
| Determining true versus apparent treatment-resistant hypertension among African Americans in the Jackson Heart Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,606,146 | September 20, 2021 | July 31, 2025 | GABRIEL, KELLEY PETTEE | reporter.nih.gov |
| Cardiometabolic Risk Development and Management in Changing Neighborhoods: the Jackson Heart Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,601,089 | August 4, 2020 | June 30, 2026 | BARBER, SHARRELLE M | reporter.nih.gov |
| Epigenetic biomarkers of preeclampsia risk among mothers with chronic hypertension | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,594,931 | January 1, 2022 | December 31, 2026 | HIDALGO, BERTHA | reporter.nih.gov |
| Effects of the DASH diet on glucose patterns in adults with type 2 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,582,175 | April 1, 2021 | March 31, 2027 | SELVIN, ELIZABETH | reporter.nih.gov |
| Facilitation of Team-based Care to Improve HTN Management and Outcomes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,577,178 | September 10, 2021 | August 31, 2027 | SHELLEY, DONNA R | reporter.nih.gov |
| Modeling Normal and Abnormal Trophoblasts | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,565,353 | September 25, 2018 | March 31, 2028 | SCHULZ, LAURA CLAMON | reporter.nih.gov |
| Blockade of calcium channels and beta adrenergic receptors for physiologic abnormalities in heart failure with preserved ejection fraction (BLOCK HFpEF) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,560,425 | September 1, 2020 | August 31, 2025 | COHEN, JORDANA B. | reporter.nih.gov |
| Digital Technology to Support Adherence to Hypertension Medications for Older Adults with Mild Cognitive Impairment | NIH | National Institute of Nursing Research | 2022 to 2024 | $2,555,971 | May 4, 2022 | April 30, 2026 | INSEL, KATHLEEN C | reporter.nih.gov |
| Adrenal Origins of Aldosterone Excess | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,547,271 | March 1, 2016 | November 30, 2025 | RAINEY, WILLIAM E | reporter.nih.gov |
| SK3 channel trafficking in endothelial cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,531,115 | July 1, 2021 | April 30, 2026 | JAGGAR, JONATHAN H | reporter.nih.gov |
| Impact of Dietary Fructose and High Salt Diet on Neurocardiovascular and Renal Function | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,521,635 | April 1, 2022 | March 31, 2027 | ROSSI, NOREEN F | reporter.nih.gov |
| Neighborhoods and health across the life course: Early life food security, diet quality, and chemical exposures | NIH | Office of the Director, National Institutes of Health | 2025 | $2,518,866 | September 1, 2023 | May 31, 2030 | OKEN, EMILY | reporter.nih.gov |
| A Rational Engineering Design Approach to Minimizing the Off-Target Effects of Baroreceptor Activation Therapy | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2025 | $2,517,805 | July 1, 2022 | March 31, 2027 | LUDWIG, KIP A | reporter.nih.gov |
| PRIMECare Trial: Preventing Ischemic Heart Disease with mHealth, electronic decision support, and Community Health Workers. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,514,537 | August 1, 2020 | May 19, 2025 | GAZIANO, THOMAS A | reporter.nih.gov |
| MatTrack: The impact of preconception maternal weight trajectories on maternal, pregnancy, and child outcomes | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,511,716 | September 1, 2021 | July 31, 2026 | VESCO, KIMBERLY KRISTINE | reporter.nih.gov |
| Contribution of neuroplasticity in the rostral ventrolateral medulla to physical inactivity-related cardiovascular disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,501,455 | December 1, 2021 | November 30, 2026 | MUELLER, PATRICK J | reporter.nih.gov |
| A South Carolina ECHO Pregnancy Cohort | NIH | Office of the Director, National Institutes of Health | 2025 | $2,496,021 | September 1, 2023 | May 31, 2030 | HUNT, KELLY J | reporter.nih.gov |
| AI-driven low-cost ultrasound for automated quantification of hypertension, preeclampsia, and IUGR | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,491,426 | September 20, 2022 | August 31, 2027 | CLIFFORD, GARI DAVID | reporter.nih.gov |
| Novel downstream effectors of protein kinase G in hypertensive disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,476,417 | April 1, 2021 | March 31, 2026 | STELZER, JULIAN | reporter.nih.gov |
| Epidemiology of Cardiac Structure and Function in African Caribbeans: The Tobago Heart Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,474,843 | August 15, 2020 | July 31, 2025 | MILJKOVIC, IVA | reporter.nih.gov |
| Improving Hypertension Medication Adherence for Older Adults | NIH | National Institute of Nursing Research | 2021 to 2024 | $2,468,604 | February 26, 2020 | December 31, 2025 | LEE, JEANNIE KIM | reporter.nih.gov |
| Per- and Polyfluoroalkyl substances mixtures and maternal cardiovascular disease risk across the reproductive life course | NIH | National Institute of Environmental Health Sciences | 2021 to 2024 | $2,455,064 | September 22, 2020 | May 19, 2025 | JAMES-TODD, TAMARRA M | reporter.nih.gov |
| Delivering Food Resources & Kitchen Skills (FoRKS) to Adults with Food Insecurity and Hypertension: An RCT | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $2,449,130 | September 22, 2022 | May 31, 2027 | CLARK, DANIEL O | reporter.nih.gov |
| ViTrack: Wearable, accurate, continuous blood pressure monitor to improve outcomes in hypertensive diseases of pregnancy | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $2,425,925 | January 15, 2023 | December 31, 2024 | THANIKACHALAM, MOHAN | reporter.nih.gov |
| Sirtuin 3 Inactivation and SOD2 Acetylation in Vascular Dysfunction and Hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,420,853 | April 21, 2021 | March 31, 2025 | DIKALOV, SERGEY | reporter.nih.gov |
| Lipid regulation of Cardiac Excitation-Contraction coupling | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,416,044 | June 1, 2022 | May 31, 2027 | DIXON, ROSE ELLEN | reporter.nih.gov |
| REACH-EpiVCID | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $2,403,545 | August 5, 2024 | July 31, 2027 | ANDERSON, CHRISTOPHER DAVID | reporter.nih.gov |
| Multi-Omics for Maternal Health after Preeclampsia | NIH | National Human Genome Research Institute | 2023 to 2025 | $2,398,471 | September 12, 2023 | May 31, 2028 | LAURENT, LOUISE CHANG | reporter.nih.gov |
| PKD proteins in endothelial cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,397,306 | February 15, 2021 | January 31, 2026 | JAGGAR, JONATHAN H | reporter.nih.gov |
| Sleep and circadian mechanisms in hypertension | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,393,150 | April 1, 2022 | March 31, 2027 | THOSAR, SAURABH SUHAS | reporter.nih.gov |
| The role of the proximal nephron in salt-sensitive hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,391,475 | January 1, 2021 | June 30, 2025 | GARVIN, JEFFREY L. | reporter.nih.gov |
| Proteomics of Hypertension and Alzheimer's Disease in African Americans | NIH | National Institute on Aging | 2021 to 2023 | $2,390,778 | September 1, 2019 | May 31, 2025 | ROBINSON, RENA A. S. | reporter.nih.gov |
| Adipose-derived sPRR controls circadian rhythm of blood pressure through inhibition of renal NCC activity | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,378,647 | July 1, 2022 | June 30, 2027 | YANG, TIANXIN | reporter.nih.gov |
| Endogenous Apelin Receptor Ligands and Early Stages of Preeclamptic Pregnancy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,370,643 | July 1, 2021 | April 30, 2026 | YAMALEYEVA, LILIYA M | reporter.nih.gov |
| Using digital health to improve diet quality among adults at risk for cardiovasclar disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,370,278 | July 1, 2019 | June 30, 2025 | BENNETT, GARY G | reporter.nih.gov |
| WNK Kinase Regulation of Thiazide-sensitive NaCl Transport | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,352,644 | August 1, 1998 | May 31, 2030 | ELLISON, DAVID HOADLEY | reporter.nih.gov |
| Uric Acid, Klotho and Salt Sensitivity in Young Adults Born Preterm | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,351,177 | August 15, 2019 | July 31, 2025 | CHAPPELL, MARK C | reporter.nih.gov |
| Eliminating racial disparities in severe maternal morbidity by addressing hypertension in the year after delivery | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $2,328,838 | August 30, 2022 | April 30, 2027 | CATOV, JANET M | reporter.nih.gov |
| Map Paravascular Fluid Dynamic Signatures of Key Aging and AD Processes Using Dynamics Diffusion-Weighted Imaging | NIH | National Institute on Aging | 2023 | $2,317,887 | September 15, 2023 | August 31, 2026 | WEN, QIUTING | reporter.nih.gov |
| Mineralocorticoid receptor, coronary microvascular function, and cardiac efficiency in hypertension | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,314,955 | January 1, 2023 | December 31, 2026 | ADLER, GAIL KURR | reporter.nih.gov |
| Role of Cytoglobin in the Regulation of Vascular Tone | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,312,927 | January 1, 2017 | November 30, 2026 | ZWEIER, JAY LOUIS | reporter.nih.gov |
| Integrating novel mechanisms controlling sodium excretion and blood pressure | NIH | National Heart, Lung, and Blood Institute | 2021 | $2,309,810 | May 1, 2017 | March 31, 2022 | POLLOCK, DAVID M | reporter.nih.gov |
| Implementation of a Combination Intervention for Sustainable Blood Pressure Control in Rural KwaZulu-Natal, South Africa (IMPACT-BP) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,299,636 | September 4, 2020 | August 31, 2025 | SIEDNER, MARK J | reporter.nih.gov |
| Angiotensin receptor G protein signal switching in AgRP neurons in cardiometabolic control | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,287,536 | January 1, 2017 | February 28, 2027 | GROBE, JUSTIN L | reporter.nih.gov |
| Clinical Implications of Blood Pressure Patterns Among Older Adults | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,286,552 | September 1, 2021 | August 31, 2025 | JURASCHEK, STEPHEN P | reporter.nih.gov |
| Scaling Out and Scaling Up the Systems Analysis and Improvement Approach to Optimize the Hypertension Diagnosis andCare Cascade for HIV-infected Individuals (SCALE SAIA HTN) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $2,285,270 | September 10, 2020 | August 31, 2025 | MOCUMBI, ANA OLGA | reporter.nih.gov |
| PERSEVERE-PEF: optimizing medical therapy saves lives in heart failure with preserved ejection fraction | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $2,281,304 | June 15, 2022 | January 31, 2025 | VOSKERICIAN, GABRIELA | reporter.nih.gov |
| Preeclampsia to cardiovascular disease: Life course analysis of biomarkers and risk | NIH | National Heart, Lung, and Blood Institute | 2021 | $2,278,257 | September 1, 2018 | August 31, 2024 | HLATKY, MARK A. | reporter.nih.gov |
| Hypertension augmented COVID-19 through renin-induced internalization of platelet-ACE2 / SARS-Cov-2 complexes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,277,916 | September 20, 2021 | August 31, 2025 | MCINTYRE, THOMAS M | reporter.nih.gov |
| Passive heat therapy for lowering systolic blood pressure and improving vascular function in mid-life and older adults | NIH | National Institute on Aging | 2022 to 2025 | $2,276,074 | April 1, 2022 | March 31, 2028 | SEALS, DOUGLAS R | reporter.nih.gov |
| SGK Regulation of Epithelial Sodium Transport | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $2,272,063 | August 15, 2000 | January 31, 2027 | PEARCE, DAVID | reporter.nih.gov |
| ENaC regulation and its role in blood pressure homeostasis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,265,124 | May 1, 1996 | June 30, 2029 | KLEYMAN, THOMAS R | reporter.nih.gov |
| Affordable Oral Delivery of Human Therapeutic Proteins Bioencapsulated in Plant Cells | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,264,934 | July 15, 2011 | August 31, 2025 | DANIELL, HENRY | reporter.nih.gov |
| Community Intervention to Reduce CardiovascuLar Disease in Chicago (CIRCL-Chicago) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,262,339 | September 10, 2020 | August 31, 2023 | KHO, ABEL N. | reporter.nih.gov |
| Sleep Quality and Mechanisms of Cardiovascular Risk in Adults with Hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,255,667 | July 1, 2019 | December 31, 2024 | SHERWOOD, ANDREW | reporter.nih.gov |
| Phone-based Interventions under Nurse Guidance after Stroke II (PINGS II) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,254,979 | April 15, 2020 | March 31, 2026 | OVBIAGELE, BRUCE | reporter.nih.gov |
| Telephone-based stress management to reduce blood pressure in Black women with hypertension in the Jackson Heart Study | NIH | National Institute on Minority Health and Health Disparities | 2022 to 2025 | $2,252,032 | August 7, 2022 | November 30, 2027 | SPRUILL, TANYA M | reporter.nih.gov |
| Angiotensin-(1-7) and Hypothalamic control of blood pressure | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,250,428 | April 1, 2021 | March 31, 2027 | ARNOLD, AMY C | reporter.nih.gov |
| Midlife cardiovascular stress physiology and preclinical cerebrovascular disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,248,100 | July 1, 2023 | June 30, 2028 | GIANAROS, PETER J | reporter.nih.gov |
| BETTER-BP (Behavioral Economics Trial To Enhance Regulation of Blood Pressure) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,240,984 | September 17, 2019 | July 31, 2025 | DODSON, JOHN A | reporter.nih.gov |
| Regulation of myocardial GPCRs by USP20 in normal and hypertrophied heart | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,237,018 | July 1, 2021 | June 30, 2025 | SHENOY, SUDHA K | reporter.nih.gov |
| Developmental Origins of Cardiovascular Disease in Offspring from Non-Human Primate Pregnancies at Advanced Maternal Age | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,235,185 | September 1, 2023 | August 31, 2027 | CILVIK, SARAH N | reporter.nih.gov |
| A lifecourse approach to women's cardiometabolic and bone health: from fertility to perimenopause | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $2,230,852 | July 10, 2019 | April 30, 2025 | OKEN, EMILY | reporter.nih.gov |
| Cardiovascular risk and circadian misalignment in short sleepers- role of extended eating period. | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,229,719 | July 1, 2023 | June 30, 2028 | SINGH, PRACHI | reporter.nih.gov |
| Kids: Nocturnal Investigation into Glomerular Disease, Hypertension, and Transcriptomics (kNIGHT) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,217,113 | March 15, 2023 | February 29, 2028 | SETHNA, CHRISTINE B | reporter.nih.gov |
| Targeting ADAM17 maturation in resistant hypertension. | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,215,089 | April 15, 2022 | March 31, 2026 | LAZARTIGUES, ERIC D | reporter.nih.gov |
| Renal electrolyte handling in females vs. males over life cycle | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,202,862 | August 1, 2010 | May 31, 2027 | MCDONOUGH, ALICIA A. | reporter.nih.gov |
| Etiology of Persistent Microalbuminuria in Nigeria | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,202,068 | July 1, 2021 | May 31, 2026 | WESTER, C. WILLIAM | reporter.nih.gov |
| Contribution of G protein coupled estrogen receptor to changes in hypothalamic plasticity and hypertension susceptibility in mice with accelerated ovarian failure | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,196,584 | February 1, 2017 | December 31, 2026 | MILNER, TERESA A | reporter.nih.gov |
| Hydrogen peroxide in endothelial function and dysfunction | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,181,657 | January 1, 2021 | December 31, 2025 | MICHEL, THOMAS | reporter.nih.gov |
| Mitochondria-mediated effects and therapeutic potential of Atrial Natriuretic Peptide in salt-sensitive hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,179,647 | August 14, 2020 | July 31, 2026 | ILATOVSKAYA, DARIA | reporter.nih.gov |
| Leptin and intermittent hypoxia interactions in the carotid bodies: mechanisms and consequences | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,155,126 | June 15, 2016 | May 31, 2029 | POLOTSKY, VSEVOLOD Y | reporter.nih.gov |
| Automated Abdominal Binder for Orthostatic Hypotension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,144,681 | January 1, 2020 | December 31, 2025 | OKAMOTO, LUIS ENRIQUE | reporter.nih.gov |
| Continuous non-invasive assessment of blood pressure profile in persons with Alzheimer's and its related dementias | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,144,152 | June 15, 2021 | May 31, 2023 | THANIKACHALAM, MOHAN | reporter.nih.gov |
| Mechanism of cardiovascular disease in premenopausal women | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,131,636 | January 1, 2021 | November 30, 2025 | BELIN DE CHANTEMELE, ERIC J | reporter.nih.gov |
| Arterial Stiffness and Wave Reflection: Physiological Contributors to CVD after Adverse Pregnancy Outcomes | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,125,559 | September 1, 2023 | August 31, 2027 | LANE, ABBI DANIELLE | reporter.nih.gov |
| Forebrain electroneutral transporters in salt-sensitive hypertension | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,113,571 | June 8, 2023 | May 31, 2028 | WENNER, MEGAN M | reporter.nih.gov |
| Acute declines in kidney function during blood pressure interventions in CKD | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $2,100,451 | May 1, 2020 | February 28, 2026 | KU, ELAINE | reporter.nih.gov |
| Integrative Genomics into Genetic Association Studies of Blood Pressure and Stroke in African Americans | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $2,098,023 | April 1, 2022 | March 31, 2026 | HSU, LI | reporter.nih.gov |
| D2 receptor variation and renal dysfunction | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,089,789 | January 20, 2023 | December 31, 2027 | JOSE, PEDRO A. | reporter.nih.gov |
| Novel MRI Assessment of Placental Structure and Function Throughout Pregnancy | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $2,087,294 | September 1, 2019 | May 31, 2025 | GRANT, PATRICIA ELLEN | reporter.nih.gov |
| Arterial Vasoregulation by Notch Signaling | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,082,599 | May 1, 2021 | April 30, 2026 | PROWELLER, AARON | reporter.nih.gov |
| Engaging Religious Leaders to Reduce Blood Pressures in Tanzanian Communities | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,078,721 | January 1, 2022 | December 31, 2026 | DOWNS, JENNIFER ALZOS | reporter.nih.gov |
| Vitamin D Deficiency, Insulin Resistance and Cardiovascular disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,078,647 | April 15, 2010 | March 31, 2027 | BERNAL-MIZRACHI, CARLOS | reporter.nih.gov |
| Scaling Telehealth Models to Improve Co-morbid Diabetes and Hypertension in Immigrant Populations | NIH | National Institute on Minority Health and Health Disparities | 2023 to 2025 | $2,070,466 | August 7, 2023 | February 29, 2028 | ISLAM, NADIA S | reporter.nih.gov |
| An Unobtrusive Continuous Cuff-less Blood Pressure Monitor for Nocturnal Hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,068,851 | June 1, 2020 | December 8, 2023 | JAFARI, ROOZBEH | reporter.nih.gov |
| Renin cell identity and blood pressure homeostasis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,063,036 | May 1, 2020 | April 30, 2025 | SEQUEIRA-LOPEZ, MARIA LUISA SOLEDAD | reporter.nih.gov |
| Integrating Hypertension and Cardiovascular Disease Care into Existing HIV Service Package in Botswana (InterCARE) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $2,062,326 | September 15, 2020 | August 31, 2025 | MOSEPELE, MOSEPELE | reporter.nih.gov |
| Benefits of nicotinamide in placental development and in preeclamsia | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $2,061,526 | August 16, 2021 | May 31, 2027 | LI, FENG | reporter.nih.gov |
| Supporting Transitions to Primary care among Under-resourced, Postpartum women: The STEP-UP | NIH | National Heart, Lung, and Blood Institute | 2022 | $2,061,152 | September 23, 2022 | August 31, 2025 | BAILEY, STACY C | reporter.nih.gov |
| Maternal Marijuana Use During Pregnancy, Marijuana Legalization, and Adverse Obstetrical and Neonatal Outcomes: A 12-year Cohort Study | NIH | National Institute on Drug Abuse | 2021 to 2023 | $2,061,059 | July 1, 2019 | April 30, 2025 | YOUNG-WOLFF, KELLY CORINNE | reporter.nih.gov |
| Effect of Renal Nerves on Chronic Kidney Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,060,887 | June 1, 2022 | March 31, 2027 | TAN, RODERICK JASON | reporter.nih.gov |
| Examining the Impact, Pathways, and Cost of County-Level Drivers of Hypertension Rates among US Adults | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,056,566 | July 20, 2022 | May 31, 2027 | DEAN, LORRAINE TIERA | reporter.nih.gov |
| Stroke Minimization through Additive Anti-atherosclerotic Agents in Routine Treatment II Study | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,050,132 | September 1, 2022 | August 31, 2027 | OVBIAGELE, BRUCE | reporter.nih.gov |
| Early Double Low-Dose Aspirin to Reduce Preeclampsia and Miscarriage: a Global Approach RCT | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $2,047,292 | August 10, 2023 | July 31, 2028 | SCHISTERMAN, ENRIQUE F. | reporter.nih.gov |
| Do no digital harm? A multilevel evaluation of technology-facilitated team care on the patient-provider relationship in health disparity populations | NIH | National Institute on Minority Health and Health Disparities | 2023 to 2025 | $2,043,755 | July 11, 2023 | January 31, 2028 | SCHOENTHALER, ANTOINETTE M | reporter.nih.gov |
| Improving outcomes for patients with SDB and insufficient sleep | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,040,339 | September 1, 2019 | July 31, 2025 | BADR, M.SAFWAN | reporter.nih.gov |
| Common Inflammation Pathways between Aging and Hypertension That Weaken Bone | NIH | National Institute on Aging | 2022 to 2025 | $2,034,707 | May 15, 2022 | January 31, 2027 | HARRISON, DAVID G | reporter.nih.gov |
| Systems Analysis and Improvement Approach to Optimize the Hypertension Diagnosis and Care Cascade for HIV-infected Individuals (SAIA-HTN) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,028,990 | May 1, 2019 | April 30, 2026 | GIMBEL, SARAH ODELL | reporter.nih.gov |
| Renal Molecular Imaging of Mesangial Cell Function with Tc-99m-Tilmanocept | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,025,043 | April 1, 2021 | February 28, 2026 | HOH, CARL K | reporter.nih.gov |
| Guiding next steps for SPRINT-MIND implementation: Identifying high-benefit subgroups and comparative effects of ARB- vs. ACEI-based regimens | NIH | National Institute on Aging | 2021 to 2023 | $2,016,471 | August 1, 2020 | April 30, 2026 | BRESS, ADAM P | reporter.nih.gov |
| Cardiovascular effects of oral bicarbonate in CKD | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,014,849 | August 24, 2022 | July 31, 2027 | RAPHAEL, KALANI LUKELA | reporter.nih.gov |
| Clinical benefits and mechanism of action of angiotensin-II receptor blocker on Cardiovascular remodeling in patients with repaired coarctation of aorta | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,012,689 | August 25, 2023 | July 31, 2028 | EGBE, ALEXANDER | reporter.nih.gov |
| Gestational hypertension and preeclampsia blood pressure (BP) Treatment goals <140/90 vs. <160/110 mmHg: The GOALPOST Trial | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $2,011,151 | July 1, 2025 | June 30, 2030 | CLIFTON, REBECCA GERSNOVIEZ | reporter.nih.gov |
| Adverse pregnancy outcomes and long-term risk of cardiovascular disease in women | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,008,590 | August 15, 2018 | July 31, 2023 | CRUMP, CASEY | reporter.nih.gov |
| Sympatho-inhibition with Mindfulness in Chronic Kidney Disease | NIH | National Center for Complementary & Integrative Health | 2022 to 2024 | $2,007,982 | September 1, 2019 | August 31, 2025 | PARK, JEANIE | reporter.nih.gov |
| Functional Microdomains in the Heart's Pacemaker: A New Dimension of Cardiac Remodeling | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,007,970 | March 1, 2018 | December 31, 2028 | GLUKHOV, ALEXEY V | reporter.nih.gov |
| A Wearable Ultrasonic System for Automatic, Continuous, and Noninvasive Monitoring of Central Blood Pressure | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2025 | $2,001,652 | June 1, 2022 | February 28, 2027 | XU, SHENG | reporter.nih.gov |
| Timing of sodium intake and nocturnal sodium excretion and blood pressure in obese African Americans | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,992,906 | August 1, 2019 | July 31, 2025 | POLLOCK, DAVID M | reporter.nih.gov |
| Partners IN CONTROL: Using Remote MonitorINg teChnology with cOmmuNity healTh woRkers to support hypertensiOn management patients at Federally QuaLified Health Centers | NIH | National Institute on Minority Health and Health Disparities | 2023 to 2025 | $1,988,140 | July 21, 2023 | January 31, 2028 | MANN, DEVIN M | reporter.nih.gov |
| Pathogenesis of renal injury and hypertension in HIV+ children | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,983,024 | April 15, 2023 | February 28, 2027 | RAY, PATRICIO E. | reporter.nih.gov |
| CD14 and Salt-Sensitive Hypertension | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,981,964 | July 1, 2022 | June 30, 2027 | MATTSON, DAVID L. | reporter.nih.gov |
| Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services | NIH | National Institute of Nursing Research | 2022 to 2025 | $1,975,628 | March 15, 2022 | December 31, 2026 | SCARTON, LISA | reporter.nih.gov |
| Modeling Multiscale Immuno-Mechanics in Aortic Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,972,386 | January 1, 2022 | December 31, 2026 | HUMPHREY, JAY D. | reporter.nih.gov |
| 2/2: A Randomized Controlled Trial of Pravastatin for the Prevention of Preeclampsia in High Risk Women | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,969,562 | August 23, 2018 | July 31, 2025 | CLIFTON, REBECCA GERSNOVIEZ | reporter.nih.gov |
| Stress, inflammation and coronary endothelial injury in preeclampsia | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,961,087 | September 2, 2022 | June 30, 2027 | HAYS, ALLISON G | reporter.nih.gov |
| A Pharmacist Intervention for Monitoring and Treating Hypertension Using Bidirectional Texting | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,956,817 | September 15, 2019 | August 31, 2025 | POLGREEN, LINNEA ANN | reporter.nih.gov |
| Biomaterial Platforms to Model the Role of Mechanical Overload in MYBPC3-Linked Hypertrophic Cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,955,125 | September 1, 2021 | August 31, 2027 | HUEBSCH, NATHANIEL | reporter.nih.gov |
| Multi-ethnic Multi-level Strategies and Behavioral Economics to Eliminate Hypertension Disparities in LA County. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,954,971 | September 10, 2020 | August 31, 2023 | BROWN, ARLEEN F. | reporter.nih.gov |
| MIND Foods and Aerobic Training in Black Adults with HTN: An ADRD Prevention Pilot RCT (MAT) | NIH | National Institute on Aging | 2023 to 2025 | $1,954,937 | March 15, 2023 | August 31, 2027 | CLARK, DANIEL O | reporter.nih.gov |
| Innovative Tools to Expand Music-Inspired Strategies for Blood Pressure and Stroke Prevention (I-TEST BP/Stroke) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,950,449 | September 29, 2023 | July 31, 2028 | IWELUNMOR, JULIET | reporter.nih.gov |
| Bayesian machine learning for causal inference with incomplete longitudinal covariates and censored survival outcomes | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,940,844 | May 15, 2022 | April 30, 2027 | HU, LIANGYUAN | reporter.nih.gov |
| Targeting Resident Cardiac Fibroblast Subpopulations for Protection Against Fibrosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,939,780 | January 1, 2022 | December 31, 2025 | HALE, TABEN M. | reporter.nih.gov |
| Managing Hypertension Among People Living with HIV: an Integrated Model (MAP-IT) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $1,939,688 | September 20, 2020 | August 31, 2025 | OJJI, DIKE BEVIS | reporter.nih.gov |
| Real-world Evidence to Inform Decisions for Hypertension Treatment Escalation | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,936,204 | August 10, 2023 | June 30, 2027 | LU, YUAN | reporter.nih.gov |
| Sex disparities in aldosterone-dependent renal Na+ transport and blood pressure control | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,933,943 | August 3, 2021 | July 31, 2026 | MAMENKO, MYKOLA | reporter.nih.gov |
| Air Pollution and Pregnancy Complications in Complex Urban Environments: Risks, Heterogeneity, and Mechanisms | NIH | National Institute of Environmental Health Sciences | 2021 to 2022 | $1,929,874 | August 1, 2019 | April 30, 2025 | WU, JUN | reporter.nih.gov |
| E-TREAT: Evaluation of Telemedicine for diabetes care in Latinos | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,927,391 | September 5, 2023 | May 31, 2028 | MARINO, MIGUEL | reporter.nih.gov |
| Lipid rafts, dopamine 1 receptor, and hypertension | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,927,098 | January 9, 2020 | December 31, 2023 | JOSE, PEDRO A. | reporter.nih.gov |
| Mechanisms of the Renoprotective Properties of Zinc Supplementation in Mouse Models of Chronic Kidney Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,923,444 | August 31, 2022 | April 30, 2027 | WILLIAMS, CLINTORIA RICHARDS | reporter.nih.gov |
| Effects of Dietary Patterns and Sodium Intake on the Gut Microbiome and Metabolome | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,913,738 | June 1, 2023 | May 31, 2028 | MUELLER, NOEL T | reporter.nih.gov |
| Early life exposure to the natural, built, and social environments and incident hypertension | NIH | National Institute of Environmental Health Sciences | 2021 to 2023 | $1,913,731 | April 2, 2019 | March 31, 2025 | LADEN, FRANCINE | reporter.nih.gov |
| Sympathetic-Vascular Dysfunction in Obesity-Related Hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,909,901 | August 1, 2021 | July 31, 2026 | HOLWERDA, SETH WILLIAM | reporter.nih.gov |
| System factors influencing the postpartum transition to primary care for cardiovascular disease risk management among women with hypertensive disorders in pregnancy | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,909,824 | April 15, 2023 | March 31, 2028 | GEISSLER, KIMBERLEY LYNN H | reporter.nih.gov |
| H2S and Uterine Vasodilation in Pregnancy and Preeclampsia | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2025 | $1,897,823 | July 20, 2021 | June 30, 2026 | CHEN, DONGBAO | reporter.nih.gov |
| Home Blood Pressure Outcomes Evaluation Study (HOMESTEAD) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,888,373 | June 1, 2022 | May 31, 2027 | DRAWZ, PAUL ENGLUND | reporter.nih.gov |
| Role of MicroRNAs in Kidney Sodium Regulation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,886,408 | May 4, 2015 | April 30, 2026 | BUTTERWORTH, MICHAEL B | reporter.nih.gov |
| Coronary artery dysfunction in OSA: Role of mineralocorticoid receptors | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,880,847 | June 1, 2023 | May 31, 2028 | BADRAN, MOHAMMAD | reporter.nih.gov |
| Epidemiology of blood pressure responses to perturbations: Correlates and prognosis for vascular risk, end-organ damage, cognitive aging and preclinical Alzheimer's disease | NIH | National Institute on Aging | 2023 to 2025 | $1,880,104 | June 1, 2022 | February 28, 2027 | RAMACHANDRAN, VASAN | reporter.nih.gov |
| Control of the Renal WNK Signaling Pathway by Phase Transitions | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,879,006 | April 1, 2014 | May 31, 2027 | SUBRAMANYA, AROHAN R | reporter.nih.gov |
| Sleep and Circadian Contributions to Nighttime Blood Pressure Rhythms (SCN-BP) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,871,291 | June 1, 2023 | May 31, 2028 | THOMAS, STEPHEN J | reporter.nih.gov |
| Chloride channels in endothelial cells | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,870,108 | March 1, 2023 | February 28, 2027 | JAGGAR, JONATHAN H | reporter.nih.gov |
| Can hydroxychloroquine prevent preeclampsia and preterm delivery in lupus pregnancy? | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases | 2021 to 2024 | $1,863,630 | August 1, 2020 | May 31, 2026 | SIMARD, JULIA F | reporter.nih.gov |
| Maternal Marijuana Use and Adverse Perinatal Outcomes | NIH | National Institute on Drug Abuse | 2021 to 2023 | $1,863,597 | September 30, 2020 | July 31, 2025 | METZ, TORRI D | reporter.nih.gov |
| Multi-Scale Modeling of Vascular Signaling Units | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,863,332 | April 16, 2020 | March 31, 2025 | SANTANA, LUIS F | reporter.nih.gov |
| Endothelial Epoxygenase, Kidney Injury, and Blood Pressure Regulation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,853,087 | June 1, 2021 | May 31, 2027 | IMIG, JOHN D | reporter.nih.gov |
| Formyl peptide receptor activation induces vascular plasticity and remodeling inhypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,849,956 | January 15, 2021 | December 31, 2025 | WENCESLAU, CAMILLA FERREIRA | reporter.nih.gov |
| Leveraging omics data to understand sleep health and its consequences among diverse Hispanics/Latinos | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,844,341 | July 1, 2022 | June 30, 2027 | SOFER, TAMAR | reporter.nih.gov |
| Chrono-exercise is Medicine: Improving Blood Pressure and Vascular Function through Chronotherapy | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,839,809 | September 1, 2023 | July 31, 2027 | CURRIE, KATHARINE DIANNE | reporter.nih.gov |
| White Matter Integrity and Cognitive Performance in Adolescents with Primary Hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,839,610 | August 14, 2010 | December 31, 2024 | LANDE, MARC B | reporter.nih.gov |
| Effect of Cardioplegia and Cardiopulmonary Bypass on Coronary Microvascular Reactivity | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,835,874 | August 1, 1992 | March 31, 2026 | SELLKE, FRANK W | reporter.nih.gov |
| Multifaceted Intervention to Improve Graft Outcome Disparities in African American Kidney Transplants (MITIGAAT) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,835,791 | July 1, 2023 | May 31, 2028 | TABER, DAVID J. | reporter.nih.gov |
| ANP Receptor: Genetic and Epigenetic Mechanisms Regulating Blood Pressure and Kidney Injury and Dysfunction | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,834,530 | September 1, 2022 | April 30, 2027 | PANDEY, KAILASH N | reporter.nih.gov |
| Mi Propio Camino (My Own Way): Addressing negative beliefs about medication to improve adherence among Hispanic adults with hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,830,728 | February 1, 2020 | January 31, 2025 | BILLIMEK, JOHN | reporter.nih.gov |
| Regulation of NKCC2 isoforms and blood pressure by tumor necrosis factor-alpha | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,830,285 | September 1, 2021 | August 31, 2025 | FERRERI, NICHOLAS R | reporter.nih.gov |
| Credentialing a Cross-Species Platform to Investigate Cancer Therapy-Associated Cardiovascular Toxicity | NIH | National Cancer Institute | 2021 to 2023 | $1,830,149 | September 1, 2019 | August 31, 2025 | JAFFE, IRIS Z | reporter.nih.gov |
| Kidney Tubular Damage and Dysfunction Identify a Novel Axis of Chronic Kidney Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,818,938 | September 20, 2019 | July 31, 2025 | IX, JOACHIM H | reporter.nih.gov |
| Targeting Pial Collaterals for Acute Stroke Treatment | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,812,697 | June 1, 2015 | November 30, 2026 | CIPOLLA, MARILYN J | reporter.nih.gov |
| Gut Metabolites, T cells, and Salt-Sensitive Hypertension | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,806,000 | January 1, 2023 | December 31, 2026 | MATTSON, DAVID L. | reporter.nih.gov |
| Sympathetic Mechanisms in the Cardiovascular and Metabolic Alterations of Obesity | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,805,911 | June 1, 2019 | May 31, 2025 | BIAGGIONI, ITALO | reporter.nih.gov |
| Regulation of Viscerosensory Sympathetic Reflexes: The Role of Diet-Derived Lipid Mediators. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,802,692 | April 1, 2020 | March 31, 2026 | O'LEARY, DONAL S | reporter.nih.gov |
| Targeting ACE2 ubiquitination for hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,801,623 | December 26, 2019 | November 30, 2025 | LAZARTIGUES, ERIC D | reporter.nih.gov |
| Remote monitoring for Equity in Advancing Control of Hypertension (REACH) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,796,537 | September 20, 2021 | August 31, 2026 | LYLES, COURTNEY REES | reporter.nih.gov |
| Neural mechanisms of host-microbiota interaction in hypertension: a potential for bio-electronic medicine | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,796,420 | June 1, 2021 | September 3, 2024 | ZUBCEVIC, JASENKA | reporter.nih.gov |
| ACCTiVATE: Achieving Chronic Care equiTy by leVeraging the Telehealth Ecosystem | NIH | National Institute on Minority Health and Health Disparities | 2023 to 2025 | $1,789,924 | September 25, 2023 | May 31, 2028 | TUOT, DELPHINE | reporter.nih.gov |
| Identification of mechano versus chemo-sensitive renal sensory neurons in hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,782,677 | April 1, 2020 | March 31, 2026 | STOCKER, SEAN D | reporter.nih.gov |
| Role of FGF21 Action in Hypothalamic Neurons in Obesity-Associated Hypertension | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,781,898 | December 15, 2022 | November 30, 2026 | RAHMOUNI, KAMAL | reporter.nih.gov |
| Role of impaired cognitive states & risk factors in conversion to mixed dementias | NIH | National Institute on Aging | 2021 to 2023 | $1,771,960 | September 1, 2011 | January 31, 2025 | KRYSCIO, RICHARD J. | reporter.nih.gov |
| Intensive Blood Pressure Control During Cardiotoxic Breast Cancer Treatment (PROTECT) Trial | NIH | National Cancer Institute | 2023 to 2025 | $1,767,760 | June 1, 2023 | May 31, 2028 | YU, ANTHONY FRANCIS | reporter.nih.gov |
| Hypothalamic BDNF-mTOR signaling promotes hypertension by increasing cardiovascular sensitivity to stress | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,766,580 | July 21, 2023 | June 30, 2027 | ERDOS, BENEDEK | reporter.nih.gov |
| Psychosocial stress, epigenetics and health disparity in hypertension | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2023 | $1,766,189 | August 28, 2019 | May 31, 2025 | SU, SHAOYONG | reporter.nih.gov |
| Neural Mechanisms of Calcineurin Inhibitor-Induced Hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,760,082 | August 1, 2020 | July 31, 2025 | PAN, HUI-LIN | reporter.nih.gov |
| Role of de novo pyrimidine biosynthesis in pathological cardiac remodeling | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,760,000 | March 1, 2022 | February 28, 2027 | WANG, ZHAO | reporter.nih.gov |
| Leveraging machine learning for cardiovascular disease risk prediction and prevention in women with a history of adverse pregnancy outcomes | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,758,775 | December 15, 2023 | November 30, 2027 | RICH-EDWARDS, JANET W | reporter.nih.gov |
| Reducing Hypertension among African American Men: A Mobile Stress Management Intervention to Address Health Disparities | NIH | National Institute on Minority Health and Health Disparities | 2023 to 2025 | $1,750,751 | September 18, 2021 | May 31, 2027 | LEAF, SAMANTHA L. | reporter.nih.gov |
| Community Health Worker Led Hypertension Prevention and Control (CHPC) in Nepal: An Implementation Trial | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,748,690 | September 1, 2023 | June 30, 2028 | SPIEGELMAN, DONNA L | reporter.nih.gov |
| Cardiovascular Disease Risk Factors in At-Risk Hispanic Women following Pregnancy Complications | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $1,747,777 | September 1, 2022 | August 31, 2027 | CHASAN-TABER, LISA | reporter.nih.gov |
| Progressive Post-Stroke Cognitive Impairment: Mechanisms & Intervention | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $1,745,096 | September 15, 2018 | August 31, 2027 | ERGUL, ADVIYE | reporter.nih.gov |
| Endothelial Piezo1 channel and cerebral blood flow control | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,734,197 | July 1, 2023 | June 30, 2028 | HARRAZ, OSAMA F | reporter.nih.gov |
| Blood Pressure and Outcomes in Contemporary Left Ventricular Assist Device Recipients | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,734,161 | June 15, 2021 | May 31, 2027 | VIDULA, HIMABINDU | reporter.nih.gov |
| Identification of Early HFpEF after Preeclampsia by Exercise Stress Testing | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,733,050 | August 20, 2024 | June 30, 2029 | LINDLEY, KATHRYN | reporter.nih.gov |
| GeNYC: Genomic Implementation Research in the Diverse Settings and Populations of New York City | NIH | National Human Genome Research Institute | 2021 to 2024 | $1,724,448 | September 14, 2024 | June 30, 2025 | HOROWITZ, CAROL R | reporter.nih.gov |
| Maternal vascular responses to extracellular mitochondrial DNA during pregnancy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,723,982 | January 1, 2020 | December 31, 2025 | GOULOPOULOU, STYLIANI | reporter.nih.gov |
| A Novel Protein Delivery System for Therapy of Preeclampsia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,698,755 | January 15, 2014 | March 31, 2026 | BIDWELL, GENE LEFLORE | reporter.nih.gov |
| Administrative Supplement to 7R01HL148060-03 Titled: Opposing Effects of Prostaglandin E2 EP3 and EP4 Receptors on Mitochondrial | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,697,970 | April 15, 2020 | January 31, 2024 | HARDING, PAMELA | reporter.nih.gov |
| LRRC8 complex regulation of endothelial function | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,696,823 | April 1, 2023 | January 31, 2027 | SAH, RAJAN | reporter.nih.gov |
| Chronic Lower Leg Heating for the Treatment of Hypertension in Older Women | NIH | National Institute on Aging | 2021 to 2023 | $1,695,508 | March 1, 2019 | December 31, 2025 | FU, QI | reporter.nih.gov |
| Nicotinamide riboside supplementation for treating arterial stiffness and elevated systolic blood pressure in patients with moderate to severe CKD | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,693,290 | May 23, 2019 | March 31, 2025 | CHONCHOL, MICHEL BENJAMIN | reporter.nih.gov |
| Integrative role of Rps6kb1 in pathological cardiac remodeling | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,693,072 | July 1, 2024 | April 30, 2028 | WANG, ZHAO | reporter.nih.gov |
| Cannabis use and cardiovascular health outcomes among patients with high blood pressure | NIH | National Institute on Drug Abuse | 2023 to 2025 | $1,692,524 | September 15, 2023 | July 31, 2028 | ALSHAARAWY, OMAYMA O | reporter.nih.gov |
| GPR75 in obesity-driven cardiovascular and metabolic complications | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,690,170 | April 1, 2023 | February 28, 2027 | SCHWARTZMAN, MICHAL LANIADO | reporter.nih.gov |
| Investigation into Arterial Stiffness and Hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,686,481 | September 1, 2020 | August 31, 2025 | SUN, ZHONGJIE | reporter.nih.gov |
| Expanding the Family Check-Up in Early Childhood to Promote Cardiovascular Health of Mothers and Young Children (ENRICH) | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,677,904 | May 16, 2022 | June 30, 2029 | CATOV, JANET M | reporter.nih.gov |
| Regulation of NKCC2 and renal NaCl transport by protein-protein interactions | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,670,578 | January 20, 2023 | December 31, 2026 | ORTIZ, PABLO A. | reporter.nih.gov |
| Mechanisms Underlying the Protective Vascular Effects of Dietary Potassium in Humans | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,669,761 | September 1, 2019 | July 31, 2025 | LENNON, SHANNON | reporter.nih.gov |
| Salt Sensitive Hypertension and Striatin | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,667,958 | January 20, 2019 | December 31, 2022 | WILLIAMS, GORDON H | reporter.nih.gov |
| Remote Patient Monitoring of Chronic Disease in Community Health Centers (REDUCE) | NIH | National Institute of Nursing Research | 2021 to 2023 | $1,662,147 | September 20, 2021 | July 31, 2025 | MCMULLEN, CARMIT KURN | reporter.nih.gov |
| Contribution of Orexin System to Hypertension | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,657,118 | April 15, 2022 | March 31, 2027 | SHAN, ZHIYING | reporter.nih.gov |
| Age-related Hypertension and Vascular Cognitive Impairment | NIH | National Institute on Aging | 2022 to 2023 | $1,638,234 | February 1, 2022 | May 31, 2023 | WAINFORD, RICHARD DAVID | reporter.nih.gov |
| Bayesian Statistical Learning for Robust and Generalizable Causal Inferences in Alzheimer Disease and Related Disorders Research | NIH | National Institute on Aging | 2023 to 2025 | $1,633,637 | February 15, 2023 | January 31, 2028 | VALERI, LINDA | reporter.nih.gov |
| Impact of the COVID-19 pandemic, SARS-CoV-2 infection and social determinants of health on pregnancy complications, birth outcomes and post-pregnancy maternal cardiovascular and mortality outcomes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $1,632,961 | April 1, 2022 | March 31, 2026 | MALEK, ANGELA M | reporter.nih.gov |
| Hypertension, Blood Pressure Targets, and Alzheimer’s Disease and Dementia Risk and Disparities among Nationally Representative US Veterans | NIH | National Institute on Aging | 2024 to 2025 | $1,629,636 | September 30, 2024 | June 30, 2029 | YAFFE, KRISTINE | reporter.nih.gov |
| Control of Renal Inflammation in Hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,624,098 | May 14, 2021 | July 15, 2023 | MATHIS, KEISA WILLIAMS | reporter.nih.gov |
| Regulation of renal ion transport by the CUL3-WNK-SPAK pathway | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,613,318 | April 1, 2014 | December 31, 2028 | MCCORMICK, JAMES A | reporter.nih.gov |
| Evaluating role of complement activation induced signaling pathways in preeclampsia pathology using a novel complement activation-based mouse model | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,605,000 | July 1, 2022 | June 30, 2027 | YALLAMPALLI, CHANDRASEKHAR | reporter.nih.gov |
| A daily diary examination of the influence of anticipated and vicarious stressors on blood pressure | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,603,666 | September 1, 2024 | May 31, 2028 | CACERES, BILLY A | reporter.nih.gov |
| The Human Cardiovascular Control: The Role of Limb Veins | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,600,185 | July 1, 2019 | May 31, 2026 | CUI, JIAN | reporter.nih.gov |
| Kidney Precision Medicine Project - Patient Engagement | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,597,606 | September 15, 2022 | June 30, 2027 | VAZQUEZ, MIGUEL A | reporter.nih.gov |
| The Relation of Soluble Klotho with Cardiovascular Disease, Chronic Kidney Disease Progression, and Blood Pressure in the Systolic Blood Pressure Intervention Trial | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,595,501 | July 15, 2021 | April 30, 2026 | DREW, DAVID ALAN | reporter.nih.gov |
| Mechanisms of Hypertension and Cardiovascular Diseases | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,590,526 | July 1, 1980 | June 30, 2026 | YOUNG, MARTIN E | reporter.nih.gov |
| Novel Calcium Signaling Nanodomains in Vascular Smooth Muscle Cells | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,590,235 | May 15, 2023 | May 31, 2027 | SONKUSARE, SWAPNIL K. | reporter.nih.gov |
| Regulation and role of leptin in preeclampsia | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,581,567 | June 15, 2023 | April 30, 2028 | FAULKNER, JESSICA L. | reporter.nih.gov |
| 12/15-lipoxygenase: Immune cell mediator linking innate immunity to hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,577,433 | December 15, 2019 | November 30, 2024 | CAMPBELL, WILLIAM BRYSON | reporter.nih.gov |
| Role of PON3 in regulating renal Na+ and K+ homeostasis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,572,280 | September 15, 2021 | August 31, 2027 | SHI, SHUJIE | reporter.nih.gov |
| Detection of extracellular vesicles in urine for diagnosis of preeclampsia | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,560,276 | September 17, 2018 | May 31, 2027 | STYBAYEVA, GULNAZ | reporter.nih.gov |
| Immune activating syncytiotrophoblast microvesicles and danger associated molecular patterns in preeclampsia risk | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2023 | $1,560,085 | July 5, 2019 | June 30, 2025 | SHARMA, SURENDRA | reporter.nih.gov |
| Endothelial PHD2 in hypertensive vascular remodeling | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,550,000 | September 1, 2021 | December 31, 2025 | CHEN, JIAN-XIONG | reporter.nih.gov |
| Role of pressure induced renal inflammation in salt-sensitive hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,547,917 | September 1, 2020 | April 30, 2026 | EVANS, LOUISE CHRISTINE | reporter.nih.gov |
| Dietary sodium, inflammation, and salt sensitivity of blood pressure | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,547,280 | September 1, 2019 | June 30, 2025 | GUPTA, DEEPAK | reporter.nih.gov |
| In Vivo Characterizations of Retinal Hemodynamics | NIH | National Eye Institute | 2022 to 2025 | $1,544,333 | September 30, 2022 | July 31, 2027 | ZHANG, YUHUA LIANG | reporter.nih.gov |
| Aldosterone and the menopausal transition's increase in blood pressure and cardiovascular risk | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,538,241 | May 20, 2024 | April 30, 2029 | BYRD, JAMES BRIAN | reporter.nih.gov |
| Hypertension, Inflammation, and Vascular Function | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,535,700 | May 19, 2020 | March 31, 2026 | CORNELIUS, DENISE CRESHUN | reporter.nih.gov |
| Effects of the renin angiotensin system on MRI volumetric measures and cognitive function in the Alzheimer's disease process: the LookAHEAD study | NIH | National Institute on Aging | 2022 to 2024 | $1,534,661 | July 1, 2022 | March 31, 2026 | YASAR, SEVIL | reporter.nih.gov |
| mGlide RCT: A Clinical Glide Path to Close the Guideline-to-Practice Gap in HTN Management | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,534,362 | July 18, 2018 | April 30, 2026 | LAKSHMINARAYAN, KAMAKSHI | reporter.nih.gov |
| Contributions of Myeloid Metabolism to Diastolic Dysfunction | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $1,533,854 | August 23, 2022 | January 31, 2025 | THORP, EDWARD BENJAMIN | reporter.nih.gov |
| Avoiding Cardiovascular Complications in Liver Transplantation through Novel Studies (ACCT NOW) in Hypertension | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,533,772 | August 15, 2024 | May 31, 2027 | VANWAGNER, LISA B | reporter.nih.gov |
| Conjugated bile acids as nutritionally re-programmable antihypertensive metabolites | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,530,450 | July 16, 2024 | May 31, 2028 | JOE, BINA | reporter.nih.gov |
| Effects of activity dependent plasticity on recovery of bladder and sexual function after human spinal cord injury | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $1,528,743 | September 23, 2014 | July 31, 2025 | HUBSCHER, CHARLES H. | reporter.nih.gov |
| Cardiovascular and neuromuscular issues in chronic pain | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,525,114 | August 1, 2024 | May 31, 2028 | AMANN, MARKUS | reporter.nih.gov |
| The 8-Aminopurine Hypothesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,520,906 | July 1, 2012 | June 30, 2024 | JACKSON, EDWIN KERRY | reporter.nih.gov |
| Lymphatic drainage dysfunction in chronic hypertension | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,520,151 | July 15, 2024 | May 31, 2028 | BENVENISTE, HELENE D | reporter.nih.gov |
| Ion Channel Dysfunction in Small Vessel Disease of the Brain | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,516,504 | April 15, 2019 | March 31, 2026 | NELSON, MARK T | reporter.nih.gov |
| The impact of blood pressure variability on neurovascular function | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,512,730 | August 15, 2023 | May 31, 2028 | FILOSA, JESSICA A | reporter.nih.gov |
| Impacts of structural racism on racial and ethnic disparities in perinatal health | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,511,191 | May 3, 2023 | February 29, 2028 | WHITWORTH, KRISTINA WALKER | reporter.nih.gov |
| The effect of antihypertensive and statin therapy on dementia incidence: a novel analytical approach in large electronic health record datasets with long follow-up times and minimal loss to follow-up | NIH | National Institute on Aging | 2024 to 2025 | $1,504,316 | December 1, 2023 | November 30, 2028 | GELDSETZER, PASCAL | reporter.nih.gov |
| Hypertension and glomerular injury in hyperhomocysteinemia - role of inflammatory exosomes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,501,062 | June 1, 1998 | May 31, 2025 | LI, PINLAN | reporter.nih.gov |
| mobile Cued Adherence Therapy (mCAT): a scalable habit formation intervention to improve blood pressure medication adherence based on a widely used smartphone app | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,497,368 | July 22, 2024 | May 31, 2029 | STECHER, CHAD DANIEL | reporter.nih.gov |
| Prenatal Blood Pressure Patterns to Predict Pregnancy-Related Hypertension and Later Life Cardiovascular Risk | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,490,862 | December 15, 2018 | November 30, 2024 | GUNDERSON, ERICA PAULINE | reporter.nih.gov |
| Leptin signaling in the carotid body: mechanisms and consequences | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,482,646 | June 15, 2016 | December 1, 2022 | POLOTSKY, VSEVOLOD Y | reporter.nih.gov |
| Role of presympathetic neurons of the hindbrain in cardiovascular control | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,480,286 | June 10, 2019 | February 28, 2025 | ABBOTT, STEPHEN | reporter.nih.gov |
| Actions of ACE2 along with Nephron to Regulate Blood Pressure | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,479,301 | October 1, 2023 | May 31, 2027 | GURLEY, SUSAN BAILEY | reporter.nih.gov |
| Neuroimmune Mechanisms of Kinin B1 Receptor in Hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,475,000 | August 15, 2020 | July 31, 2025 | SRIRAMULA, SRINIVAS | reporter.nih.gov |
| CXCL12 regulation of placental development and fetal health | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,474,720 | May 17, 2021 | April 30, 2025 | ASHLEY, RYAN LYNN | reporter.nih.gov |
| Angiotensin-(1-7) and Cardiovascular Derangements in Obesity Hypertension | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,468,957 | April 15, 2024 | March 31, 2029 | ARNOLD, AMY C | reporter.nih.gov |
| Remote monitoring for Equity in Advancing Control of Hypertension (REACH) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,467,016 | September 20, 2021 | June 30, 2023 | LYLES, COURTNEY REES | reporter.nih.gov |
| Effect of a technology-based collaborative care model on persistent hypertension and preventive careattendance among postpartum people with hypertensive disorders of pregnancy | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,465,475 | August 15, 2024 | June 30, 2029 | LEWKOWITZ, ADAM KORRICK | reporter.nih.gov |
| Effects of Experimental Sleep Restriction in Offspring of Hypertensive Parents | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,464,939 | May 1, 2024 | April 30, 2029 | COVASSIN, NAIMA | reporter.nih.gov |
| Retinal vasculature in hypertension | NIH | National Eye Institute | 2022 to 2025 | $1,460,000 | September 30, 2022 | June 30, 2027 | HARRIS, NORMAN R | reporter.nih.gov |
| Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $1,456,041 | June 15, 2020 | May 31, 2026 | BROWN, NANCY J. | reporter.nih.gov |
| Vascular Mechanisms of Hypertension-in-Pregnancy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,445,394 | September 1, 2020 | August 31, 2025 | KHALIL, RAOUF A | reporter.nih.gov |
| Hypertension, brain clearance and markers of neurodegeneration | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,431,349 | August 1, 2018 | April 30, 2025 | GLODZIK, LIDIA | reporter.nih.gov |
| The protective role of microglia in preventing hypoxic disruption of blood-brain barrier integrity and VCID | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,423,377 | February 15, 2021 | January 31, 2027 | MILNER, D. RICHARD | reporter.nih.gov |
| Role of basolateral K channels in renal salt handling and BP control | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,416,997 | July 1, 2021 | November 30, 2024 | PALYGIN, OLEG | reporter.nih.gov |
| Mechanisms of morbidity after correcting aortic coarctations of varying severity | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,415,421 | July 1, 2018 | April 30, 2028 | LADISA, JOHN FRANK | reporter.nih.gov |
| Novel Role Of ACTN4 in Sodium Reabsorption and Salt-Sensitive Hypertension | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,413,578 | December 15, 2023 | November 30, 2027 | FENG, DI | reporter.nih.gov |
| Development of Non-invasive Liquid Biopsy Screening Tool for Preterm Birth Causes and Consequences | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,410,779 | August 13, 2024 | July 31, 2029 | PETERS, DAVID GERARD | reporter.nih.gov |
| A large scale investigation of the vaginal ecosystem in preeclampsia | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,409,507 | September 3, 2024 | August 31, 2029 | KOREM, TAL | reporter.nih.gov |
| Cardiovascular Health After Placental Abruption (CHAP) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $1,401,945 | August 13, 2020 | June 30, 2026 | ANANTH, CANDE V. | reporter.nih.gov |
| The Effects of Diet and Exercise Interventions in Peripheral Artery Disease | NIH | National Institute on Aging | 2024 to 2025 | $1,400,216 | September 1, 2022 | May 31, 2027 | GARDNER, ANDREW W | reporter.nih.gov |
| Kidney-Associated Diseases after Congenital Heart disease surgery In Children | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,396,868 | March 15, 2024 | January 31, 2028 | PARIKH, CHIRAG R | reporter.nih.gov |
| Expanding the Family Check-Up in Early Childhood to Promote Cardiovascular Health of Mothers and Young Children (ENRICH) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $1,393,874 | May 16, 2022 | June 30, 2024 | CATOV, JANET M | reporter.nih.gov |
| Pediatric Ambulatory Blood Pressure Trajectory and Brain Health in Midlife | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,392,218 | June 1, 2019 | April 30, 2024 | SU, SHAOYONG | reporter.nih.gov |
| A Team-Based and Technology Driven Adherence Intervention to Improve Chronic Disease Outcomes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,388,532 | February 15, 2018 | January 31, 2025 | SPERL-HILLEN, JOANN M | reporter.nih.gov |
| Drinking water salinity in a hot-dry environment: Hydration, kidney function, and blood pressure | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $1,387,992 | September 20, 2024 | June 30, 2029 | ROSINGER, ASHER Y. | reporter.nih.gov |
| Identification of a mechanosensor in juxtaglomerular cells for the regulation of renin synthesis and secretion | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,386,531 | January 15, 2024 | December 31, 2028 | WEI, JIN | reporter.nih.gov |
| Identifying optimal dietary patterns for postpartum cardiovascular disease prevention | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,383,783 | August 15, 2024 | April 30, 2028 | BODNAR, LISA M | reporter.nih.gov |
| ELUCIDATING MECHANISMS OF THORACIC AORTOPATHY VIA COMPUTATIONAL MODELING | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,375,751 | July 10, 2024 | June 30, 2028 | HUMPHREY, JAY D. | reporter.nih.gov |
| Sympathetic Regulation of Large Artery Stiffness in Humans with Age-Related Isolated Systolic Hypertension | NIH | National Institute on Aging | 2021 to 2024 | $1,375,652 | April 15, 2020 | July 31, 2025 | PIERCE, GARY L. | reporter.nih.gov |
| Panx1-PIEZO1 Interactions Regulate Renin Release | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,373,546 | July 1, 2024 | June 30, 2028 | ISAKSON, BRANT E | reporter.nih.gov |
| Role of obesity in blood pressure regulation and insulin resistance in Polycystic Ovary Syndrome | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,368,130 | December 1, 2023 | November 30, 2028 | YANES CARDOZO, LICY LORENA | reporter.nih.gov |
| Significance of Epac signaling in renal Na+handling and hypertension | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,357,132 | August 19, 2024 | June 30, 2028 | POCHYNYUK, OLEH | reporter.nih.gov |
| ATP1A1-dependent Regulation of Sodium Handling by the Renal Proximal Tubule: Mechanism and Implications in Salt-Sensitivity | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,353,401 | August 24, 2021 | June 30, 2026 | PIERRE, SANDRINE V | reporter.nih.gov |
| Epigenetic Regulation of Kidney Function and Blood Pressure | NIH | National Institute on Aging | 2021 to 2023 | $1,353,364 | May 1, 2019 | February 28, 2026 | SUN, ZHONGJIE | reporter.nih.gov |
| Nicotinamide riboside supplementation for treating elevated systolic blood pressure and arterial stiffness in middle-aged and older adults | NIH | National Institute on Aging | 2021 to 2023 | $1,353,296 | February 1, 2019 | November 30, 2025 | SEALS, DOUGLAS R | reporter.nih.gov |
| Transforming Hypertension Management in Nigeria | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $1,337,928 | May 15, 2019 | February 28, 2025 | HUFFMAN, MARK D | reporter.nih.gov |
| Olfactory Receptor 558 (OLFR558) Ligands and Blood Pressure Regulation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,336,996 | January 15, 2024 | December 31, 2027 | PLUZNICK, JENNIFER L | reporter.nih.gov |
| Soluble (pro)renin receptor regulation of kidney fibrosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,336,755 | July 1, 2023 | May 31, 2028 | RAMKUMAR, NIRUPAMA | reporter.nih.gov |
| Antihypertensive Mechanisms of Minocycline in Resistant Hypertension: Role of the gut microbiota-brain-immune axis | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,332,965 | December 15, 2023 | January 31, 2029 | SMITH, STEVEN MICHAEL | reporter.nih.gov |
| The circadian clock protein BMAL and post-translational regulation of ENaC in the kidney | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,328,580 | July 1, 2020 | June 30, 2026 | ALLI, ABDEL AYUBE | reporter.nih.gov |
| Structures and Pharmacology of Cation-Chloride Cotransporters | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,328,580 | September 20, 2021 | August 31, 2025 | CAO, ERHU | reporter.nih.gov |
| 2/2 Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia Phenotypes Based on Objective Sleep Duration: A Sequential Cohort/Randomized Controlled Trial | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,322,128 | July 1, 2023 | June 30, 2028 | WISNIEWSKI, STEPHEN R | reporter.nih.gov |
| Intratubular Angiotensin II and AT1a Receptors in The Proximal Tubules: Roles in Hypertension and Kidney Injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,320,228 | May 18, 2020 | April 30, 2025 | ZHUO, JIA LONG | reporter.nih.gov |
| Promoting stretching exercise to reduce cardiovascular health risk in late pregnant women with obesity | NIH | National Institute of Nursing Research | 2021 to 2024 | $1,319,915 | August 6, 2019 | April 30, 2025 | YEO, SEONAE | reporter.nih.gov |
| Blood Trauma, Vascular Remodeling, and Vasoregulation with Total Body Continuous Versus Pulsatile Artificial Circulation | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,318,895 | August 9, 2024 | May 31, 2029 | BARTOLI, CARLO R | reporter.nih.gov |
| EGF-ADAM17 axis in the pathophysiology of intracranial aneurysm | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,313,346 | September 30, 2019 | August 31, 2025 | HASHIMOTO, TOMOKI | reporter.nih.gov |
| Assessment of the Impact of antihypertensive Medications on vascular and renal outcomes in Chronic Kidney Disease (AIM-CKD) | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,312,532 | July 1, 2024 | April 30, 2028 | WANG, MING | reporter.nih.gov |
| Mechanisms of HIV-associated Hypertension | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,311,860 | September 1, 2024 | August 31, 2028 | BELIN DE CHANTEMELE, ERIC J | reporter.nih.gov |
| Building a kidney monitoring panel to guide therapy in resistant hypertension | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,311,757 | July 1, 2024 | June 30, 2028 | GUPTA, RAJESH | reporter.nih.gov |
| Unpacking the Mechanisms of Disparities for HIV-related Hypertension in African American and Asian Pacific American MSM | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2022 | $1,306,467 | September 1, 2018 | February 29, 2024 | WONG, FRANK Y. | reporter.nih.gov |
| Neural Mechanisms of Hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,293,576 | December 15, 2014 | July 31, 2024 | FENG EARLEY, YUMEI | reporter.nih.gov |
| Novel mechanisms and predictors of VEGF receptor inhibitor-associated hypertension | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $1,293,078 | June 15, 2022 | May 31, 2025 | MOSLEHI, JAVID J | reporter.nih.gov |
| Renal Denervation in Heart Failure with Preserved Ejection Fraction | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,285,416 | August 1, 2021 | December 31, 2022 | GOODCHILD, TRACI TAYLOR | reporter.nih.gov |
| SHePREG: Study of Heart function in PRE-Eclampsia during and after PreGnancy | NIH | National Heart, Lung, and Blood Institute | 2025 | $1,284,381 | January 14, 2025 | December 31, 2029 | BRADLEY, ELISA ANN | reporter.nih.gov |
| Sex Differences in Blood Pressure and Olfactory Receptor 558 (OLFR558) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,280,733 | May 3, 2024 | March 31, 2028 | PLUZNICK, JENNIFER L | reporter.nih.gov |
| 5-HT7 receptor and blood pressure regulation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,275,555 | April 1, 2020 | January 31, 2025 | WATTS, STEPHANIE W | reporter.nih.gov |
| Immune Modulation in Hypertension | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $1,268,906 | June 10, 2022 | August 14, 2023 | MADHUR, MEENAKSHI SWAMINATHAN | reporter.nih.gov |
| PT4A (Peers and Technology for Adherence, Access, Accountability, and Analytics) | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,262,948 | May 23, 2024 | April 30, 2028 | VEDANTHAN, RAJESH | reporter.nih.gov |
| Adverse pregnancy outcomes and long-term risk of cardiovascular disease in women | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,262,405 | August 16, 2023 | April 30, 2027 | CRUMP, CASEY | reporter.nih.gov |
| Novel Roles and Mechanisms of Proximal Tubule Mitochondrial Angiotensin II and Sirtuin 3 in Hypertension | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,257,160 | March 1, 2020 | April 30, 2030 | ZHUO, JIA LONG | reporter.nih.gov |
| Reducing the risk of chronic hypertension and improving vascular function following preeclampsia | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,256,794 | July 3, 2024 | June 30, 2029 | PALATNIK, ANNA | reporter.nih.gov |
| MINDBP - Mindfulness and Wearable Biosensors to Prevent Hypertensive Disorders of Pregnancy | NIH | National Center for Complementary & Integrative Health | 2025 | $1,256,373 | September 22, 2025 | August 31, 2028 | PALATNIK, ANNA | reporter.nih.gov |
| Angiotensin-sensitive neurons in the nucleus of the solitary tract mediate social stress induced hypertension | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,253,312 | December 1, 2017 | December 31, 2026 | DE KLOET, ANNETTE DIANE | reporter.nih.gov |
| Placental Organoids to Model Preeclampsia | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,252,500 | December 15, 2022 | November 30, 2026 | KARUMANCHI, S. ANANTH | reporter.nih.gov |
| Mechanisms of Vascular Toxicity from Inhaled Toxicants | NIH | National Institute of Environmental Health Sciences | 2021 to 2023 | $1,252,412 | May 1, 2008 | July 31, 2025 | CAMPEN, MATTHEW J | reporter.nih.gov |
| The Risk of Developing Alzheimer’s Disease and Related Dementias Associated with Hypertension, Diabetes, and Drug Therapies for Cancer: Up to 30-year Follow-up for Older Medicare Beneficiaries | NIH | National Institute on Aging | 2021 to 2024 | $1,248,000 | May 1, 2020 | January 31, 2026 | DU, XIANGLIN | reporter.nih.gov |
| Microvascular endothelial Kir channels in flow-induced dilation and hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,247,790 | April 19, 2019 | March 31, 2025 | LEVITAN, IRENA | reporter.nih.gov |
| Polygenic Risk Scores for Diverse Populations - Bridging Research and Clinical Care | NIH | National Heart, Lung, and Blood Institute | 2021 | $1,245,107 | August 20, 2020 | March 14, 2022 | KOOPERBERG, CHARLES L | reporter.nih.gov |
| The ADHINCRA Study: Addressing HypertensIoN Care in AfRicA | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,243,294 | September 15, 2024 | June 30, 2029 | COMMODORE-MENSAH, YVONNE | reporter.nih.gov |
| Learn-As-you-GO (LAGO): An innovative adaptive design for multi-component intervention studies in cardiology and public health | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,242,889 | February 15, 2024 | January 31, 2028 | SPIEGELMAN, DONNA L | reporter.nih.gov |
| Unraveling the Impact of Estrogen Signaling on Postmenopausal Hypertension | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,232,232 | June 7, 2024 | April 30, 2029 | GOHAR, EMAN | reporter.nih.gov |
| FHS-NEXT - Framingham Novel EXam using Technology | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,231,570 | December 15, 2018 | November 30, 2024 | MURABITO, JOANNE M | reporter.nih.gov |
| Aging and hypertension: Integrated renal and sympathetic control of blood pressure | NIH | National Institute on Aging | 2021 to 2023 | $1,230,521 | September 30, 2019 | June 2, 2023 | WAINFORD, RICHARD DAVID | reporter.nih.gov |
| NOX4-associated oxidative stress mediates vascular and kidney impairment in the low birth weight adult | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,230,000 | December 15, 2019 | November 30, 2025 | RATLIFF, BRIAN BLAKE | reporter.nih.gov |
| Mechanisms of mindfulness training to reduce maternal and infant cardiovascular disease risk | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,228,181 | May 15, 2024 | April 30, 2029 | BUBLITZ, MARGARET | reporter.nih.gov |
| Hypothalamic astrocyte-neuron relationship links overnutrition to hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,222,624 | March 15, 2019 | January 31, 2025 | CAI, DONGSHENG | reporter.nih.gov |
| Regulation of kidney function and blood pressure in aging | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,214,215 | April 1, 2024 | March 31, 2028 | SUN, ZHONGJIE | reporter.nih.gov |
| Stem Cell-based Modeling of Placental Defects associated with Early-Onset Preeclampsia | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $1,212,764 | July 1, 2024 | April 30, 2029 | HORII, MARIKO | reporter.nih.gov |
| Degenerin and TrpC6 channels in renal vascular mechanosesnsor signaling and protection against injury. | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,209,764 | April 1, 2024 | March 31, 2028 | DRUMMOND, HEATHER A | reporter.nih.gov |
| Scaling Up Community-based Noncommunicable Disease Research into Practice in Pokhara Metropolitan City of Nepal (SCALE-NCD) | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,209,569 | March 1, 2024 | February 28, 2029 | NEUPANE, DINESH | reporter.nih.gov |
| PopulAtioN health management to OPTImize Care in CKD (PANOPTIC-CKD) | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $1,207,723 | August 1, 2018 | July 31, 2024 | ABDEL-KADER, KHALED A | reporter.nih.gov |
| Causal mechanisms in adolescent arterial stiffness | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,201,764 | September 1, 2019 | August 31, 2025 | ZACHARIAH, JUSTIN P.V. | reporter.nih.gov |
| Reach Out 2: Randomized Clinical Trial of Emergency Department-Initiated Hypertension Mobile Health Intervention Connecting Multiple HealthSystems | NIH | National Institute on Minority Health and Health Disparities | 2023 to 2025 | $1,201,620 | September 24, 2023 | November 30, 2028 | SKOLARUS, LESLI ELIZABETH | reporter.nih.gov |
| Regulation of arterial diameter through specific sensing of endogenous steroids and novel nonsteroidal analogs by BK channel subunits | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,200,610 | March 20, 2019 | January 31, 2026 | DOPICO, ALEX M. | reporter.nih.gov |
| A Smart Ring for Cuffless Blood Pressure to Reduce Health Disparities in People of Color | NIH | National Institute of Biomedical Imaging and Bioengineering | 2024 to 2025 | $1,195,689 | July 15, 2023 | April 30, 2028 | JAFARI, ROOZBEH | reporter.nih.gov |
| Gestational Hyperandrogenism in Cardiovascular Programming | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $1,194,769 | September 4, 2020 | August 31, 2025 | VYAS, ARPITA | reporter.nih.gov |
| Potentiation of CAA-mediated endothelial dysfunction by cardiovascular risk factors | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,192,416 | August 1, 2018 | April 30, 2025 | FOSSATI, SILVIA | reporter.nih.gov |
| Vanderbilt Hypertension and Blood Pressure Regulation Program | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,187,740 | February 1, 2019 | January 31, 2025 | HARRISON, DAVID G | reporter.nih.gov |
| Blood Pressure and Outcomes in Contemporary Left Ventricular Assist Device Recipients | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,184,201 | June 15, 2021 | May 31, 2023 | VIDULA, HIMABINDU | reporter.nih.gov |
| Angiotensin-sensitive neurons in the nucleus of the solitary tract mediate social stress induced hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,183,760 | December 1, 2017 | September 1, 2023 | DE KLOET, ANNETTE DIANE | reporter.nih.gov |
| Role of tubuloglomerular feedback in the development of hypertension in diabetes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,182,148 | April 19, 2019 | March 31, 2024 | LIU, RUISHENG | reporter.nih.gov |
| Understanding Racial/Ethnic Disparities in Clinician Concordance with Hypertension Treatment Guidelines and Blood Pressure Control | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,178,532 | September 1, 2024 | June 30, 2028 | TEDLA, YACOB G | reporter.nih.gov |
| Analytic Methods to Inform Interventions that Advance Cardiovascular Health Equity | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,178,151 | April 1, 2024 | March 31, 2029 | JACKSON, JOHN WILLIAM | reporter.nih.gov |
| Mediator kinase regulation of cardiac transcription | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,174,498 | July 5, 2024 | April 30, 2029 | GRUETER, CHAD E | reporter.nih.gov |
| A double-blind randomized controlled trial to assess the efficacy and safety of a quadruple ultra-low dose treatment for hypertension (QUARTET USA) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $1,173,117 | June 15, 2018 | July 31, 2025 | HUFFMAN, MARK D | reporter.nih.gov |
| The role of kidney epithelial cells specific EP4 receptors in blood pressure control | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,169,872 | September 23, 2022 | April 30, 2027 | YANG, TING | reporter.nih.gov |
| Adducin, actin cytoskeleton and cognitive impairments | NIH | National Institute on Aging | 2021 to 2023 | $1,162,500 | April 1, 2019 | January 31, 2025 | WILLIAMS, JAN MICHAEL | reporter.nih.gov |
| Vasopressin and Preeclampsia: Early Mechanisms for Prevention | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $1,160,487 | January 23, 2019 | December 31, 2024 | SANTILLAN, MARK K | reporter.nih.gov |
| Policy Change and Women's Health | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $1,145,664 | June 15, 2019 | May 31, 2025 | MARGERISON, CLAIRE E | reporter.nih.gov |
| Immune Modulation in Hypertension | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,144,375 | October 20, 2023 | February 28, 2027 | MADHUR, MEENAKSHI SWAMINATHAN | reporter.nih.gov |
| Improving Outcomes in Kidney Disease Using Systems-Driven Education and Coaching | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $1,139,373 | December 26, 2017 | November 30, 2024 | WRIGHT, JULIE ANNE | reporter.nih.gov |
| How Do Policies Pre-Conception, at Delivery, and Postpartum Shape Maternal and Infant Health Outcomes and Disparities? | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $1,127,814 | September 11, 2025 | August 31, 2027 | ROSSIN-SLATER, MAYA | reporter.nih.gov |
| Control of Renal Inflammation in Hypertension | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,125,986 | May 14, 2021 | April 30, 2027 | MATHIS, KEISA W | reporter.nih.gov |
| Ethical, multimodal AI tool for prediction of preeclampsia risk in early pregnancy | NIH | Office of the Director, National Institutes of Health | 2025 | $1,123,145 | September 1, 2025 | August 31, 2026 | KOVACHEVA, VESELA | reporter.nih.gov |
| Brain NaCl-sensing in salt-sensitive hypertension. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,118,934 | July 10, 2019 | April 30, 2025 | STOCKER, SEAN D | reporter.nih.gov |
| Stromal interaction molecule 1, immune cells, and vascular pathology in established hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,108,121 | July 1, 2020 | June 25, 2024 | MATROUGUI, KHALID | reporter.nih.gov |
| A double-blind randomized controlled trial to assess the efficacy and safety of a quadruple ultra-low-dose treatment for hypertension (QUARTET USA) | NIH | National Heart, Lung, and Blood Institute | 2021 | $1,104,047 | June 15, 2018 | December 31, 2021 | HUFFMAN, MARK D | reporter.nih.gov |
| Blood Pressure and ADRD in African Americans: the Jackson Heart Study | NIH | National Institute on Aging | 2023 | $1,102,700 | September 15, 2019 | May 31, 2026 | PALTA, PRIYA | reporter.nih.gov |
| Renal and Electrolyte Disease and Hypertension | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,102,579 | July 1, 1983 | June 30, 2026 | KENDRICK, JESSICA B | reporter.nih.gov |
| Gut microbiota-mediated fiber fermentation in HIV-associated cardiovascular disease | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,102,000 | April 15, 2024 | March 31, 2029 | VUJKOVIC-CVIJIN, IVAN | reporter.nih.gov |
| Intersection of the PPARγ-RhoBTB1-Cullin-3 Pathway and Renin-Angiotensin System in Blood Pressure, Vascular Function and Arterial Stiffness | NIH | National Heart, Lung, and Blood Institute | 2025 | $1,092,000 | May 1, 2025 | April 30, 2032 | SIGMUND, CURT DANIEL | reporter.nih.gov |
| Clinical validation of NS-0200, a fixed combination drug product for the treatment of hypertension | NIH | National Heart, Lung, and Blood Institute | 2025 | $1,084,359 | September 15, 2025 | June 30, 2027 | ZEMEL, MICHAEL B. | reporter.nih.gov |
| Renal ion channels in the control of blood pressure | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $1,083,291 | January 15, 2017 | December 31, 2023 | STARUSCHENKO, ALEXANDER | reporter.nih.gov |
| Cardiac microtubules as regulators of diastolic function. | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,080,730 | December 12, 2023 | November 30, 2028 | CAPORIZZO, MATTHEW | reporter.nih.gov |
| ACES - ACE inhibitors Combined with Exercise for hypertensive Seniors | NIH | National Institute on Aging | 2021 to 2022 | $1,078,139 | September 15, 2017 | May 31, 2023 | BUFORD, THOMAS W | reporter.nih.gov |
| Physiology of ClC-K2/b Cl- channel in the collecting duct | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,053,000 | September 15, 2019 | June 30, 2025 | POCHYNYUK, OLEH | reporter.nih.gov |
| Molecular mechanisms of progranulin as a regulator of endothelial biology and blood pressure control | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,045,238 | September 3, 2024 | April 30, 2029 | BRUDER, THIAGO | reporter.nih.gov |
| Targeting of UnControlled Hypertension in Emergency Department (TOUCHED) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,041,141 | September 5, 2018 | August 31, 2024 | PRENDERGAST, HEATHER MARIE | reporter.nih.gov |
| The Role of the Hippocampal Vasculature in Vascular Cognitive Impairment and Dementia | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,029,468 | April 1, 2022 | March 31, 2027 | CHAPMAN, ABBIE C | reporter.nih.gov |
| Afferent renal nerves, renal inflammation, and hypertension | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,022,386 | December 15, 2013 | October 31, 2023 | OSBORN, JOHN W | reporter.nih.gov |
| Factor XIIa is the long-sought activator of circulating renin in heart failure. | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,017,906 | July 1, 2024 | June 30, 2028 | GLADYSHEVA, INNA P | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| Westat, Inc. | Bethesda, MD | 1 | $367.1 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 26 | $55.5 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 37 | $48.1 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 31 | $48 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 20 | $47.5 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 26 | $41.5 million | 0 | $0 |
| Icf, Inc., LLC | Fairfax, VA | 1 | $31.9 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 30 | $31.6 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 21 | $31.4 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 18 | $31 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 9 | $29.7 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 19 | $28.8 million | 0 | $0 |
| University of Utah | Salt Lake City, UT | 24 | $26.9 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 12 | $23.7 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 16 | $23.5 million | 0 | $0 |
| Tulane University of Louisiana | New Orleans, LA | 13 | $22.8 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 21 | $22.3 million | 0 | $0 |
| Wake Forest University Health Sciences | Winston-Salem, NC | 12 | $22.2 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 16 | $21.6 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 14 | $21.4 million | 0 | $0 |
| Medical College of Wisconsin | Milwaukee, WI | 21 | $21.2 million | 0 | $0 |
| Augusta University | Augusta, GA | 18 | $20.3 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 11 | $19.8 million | 0 | $0 |
| University of Mississippi Med CTR | Jackson, MS | 34 | $19.4 million | 0 | $0 |
| Harvard University D/b/a Harvard School of Public Health | Boston, MA | 9 | $19.4 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 13 | $19.3 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 12 | $18 million | 0 | $0 |
| Rush University Medical Center | Chicago, IL | 3 | $17.9 million | 0 | $0 |
| Yale University | New Haven, CT | 23 | $17.6 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 19 | $17.6 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 11 | $17.6 million | 0 | $0 |
| George Washington University | Washington, DC | 10 | $17.5 million | 0 | $0 |
| Research Triangle Institute | Research Triangle Park, NC | 1 | $17.4 million | 0 | $0 |
| Washington University | Saint Louis, MO | 12 | $17.1 million | 0 | $0 |
| Kaiser Foundation Research Institute | Oakland, CA | 9 | $16.6 million | 0 | $0 |
| Wayne State University | Detroit, MI | 12 | $16.6 million | 0 | $0 |
| University of Tennessee Health Sci CTR | Memphis, TN | 9 | $16.1 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 17 | $15 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 12 | $15 million | 0 | $0 |
| University of Florida | Gainesville, FL | 18 | $14.8 million | 0 | $0 |
| Duke University | Durham, NC | 15 | $14.3 million | 0 | $0 |
| Beth Israel Deaconess Medical Center | Boston, MA | 8 | $14.3 million | 0 | $0 |
| University of Kansas Medical Center | Kansas City, KS | 3 | $13.8 million | 0 | $0 |
| LSU Pennington Biomedical Research CTR | Baton Rouge, LA | 2 | $13.8 million | 0 | $0 |
| University of Washington | Seattle, WA | 8 | $13.5 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 10 | $13.5 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 14 | $12.1 million | 0 | $0 |
| Stanford University | Stanford, CA | 11 | $11.7 million | 0 | $0 |
| Medical University of South Carolina | Charleston, SC | 12 | $11.7 million | 0 | $0 |
| Magee-Women's Res Inst and Foundation | Pittsburgh, PA | 7 | $11.4 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 9 | $11.1 million | 0 | $0 |
| University of Vermont & ST Agric College | Burlington, VT | 9 | $10.4 million | 0 | $0 |
| Emory University | Atlanta, GA | 15 | $10.3 million | 0 | $0 |
| University of Missouri-Columbia | Columbia, MO | 9 | $10 million | 0 | $0 |
| Tufts Medical Center | Boston, MA | 5 | $9.9 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 15 | $9.7 million | 0 | $0 |
| Boston University Medical Campus | Boston, MA | 10 | $9 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 5 | $8.8 million | 0 | $0 |
| University of Texas HLTH Sci CTR Houston | Houston, TX | 8 | $8.8 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 4 | $8.7 million | 0 | $0 |
| University of Rochester | Rochester, NY | 9 | $8.6 million | 0 | $0 |
| University of Delaware | Newark, DE | 8 | $8.1 million | 0 | $0 |
| Northern California Institute/res/edu | San Francisco, CA | 4 | $7.9 million | 0 | $0 |
| University of Colorado at Boulder | Boulder, CO | 7 | $7.7 million | 0 | $0 |
| Pennsylvania State Univ Hershey Med CTR | Hershey, PA | 7 | $7.5 million | 0 | $0 |
| University of Toledo Health Sci Campus | Toledo, OH | 10 | $7.3 million | 0 | $0 |
| University of Abuja | Abuja | 5 | $7.3 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 8 | $6.8 million | 0 | $0 |
| Cedars-Sinai Medical Center | Los Angeles, CA | 10 | $6.4 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 3 | $6.4 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 6 | $6.4 million | 0 | $0 |
| University of California at Davis | Davis, CA | 4 | $6.3 million | 0 | $0 |
| Beckman Research Institute/city of Hope | Duarte, CA | 3 | $6.3 million | 0 | $0 |
| New York Medical College | Valhalla, NY | 6 | $6.2 million | 0 | $0 |
| LSU Health Sciences Center | New Orleans, LA | 5 | $5.9 million | 0 | $0 |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 5 | $5.5 million | 0 | $0 |
| Michigan State University | East Lansing, MI | 6 | $5.4 million | 0 | $0 |
| University of the West Indies | Saint Augustine | 2 | $5.4 million | 0 | $0 |
| Virginia Commonwealth University | Richmond, VA | 6 | $5.3 million | 0 | $0 |
| University of Chicago | Chicago, IL | 4 | $5.3 million | 0 | $0 |
| University of North Texas HLTH Sci CTR | Fort Worth, TX | 4 | $5.3 million | 0 | $0 |
| University of South Florida | Tampa, FL | 10 | $5.2 million | 0 | $0 |
| Dynocardia, Inc. | Lowell, MA | 3 | $5.1 million | 0 | $0 |
| University of Kentucky | Lexington, KY | 8 | $5 million | 0 | $0 |
| Universidad Peruana Cayetano Heredia | Lima | 2 | $4.8 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 6 | $4.8 million | 0 | $0 |
| Harvard Pilgrim Health Care, Inc. | Canton, MA | 2 | $4.7 million | 0 | $0 |
| Univ of Arkansas for Med Scis | Little Rock, AR | 3 | $4.6 million | 0 | $0 |
| Ohio State University | Columbus, OH | 7 | $4.6 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 4 | $4.4 million | 0 | $0 |
| Infectious Diseases Res Collaboration | Kampala | 3 | $4.1 million | 0 | $0 |
| Wits Health Consortium (pty), LTD | Parktown | 2 | $4 million | 0 | $0 |
| Miriam Hospital | Providence, RI | 2 | $4 million | 0 | $0 |
| Vanderbilt University | Nashville, TN | 4 | $3.7 million | 0 | $0 |
| Texas A&m University Health Science CTR | College Station, TX | 3 | $3.5 million | 0 | $0 |
| University of Hawaii | Honolulu, HI | 2 | $3.5 million | 0 | $0 |
| Texas A&M Engineering Experiment Station | College Station, TX | 4 | $3.4 million | 0 | $0 |
| Georgia State University | Atlanta, GA | 5 | $3.4 million | 0 | $0 |
| Cornell University | Ithaca, NY | 1 | $3.4 million | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 3 | $3.3 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 523 | $367,094,879 | 0 | $0 |
| 2024 | 574 | $367,826,830 | 0 | $0 |
| 2023 | 604 | $441,218,316 | 0 | $0 |
| 2022 | 611 | $395,929,654 | 0 | $0 |
| 2021 | 607 | $356,141,078 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 4, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-04). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.